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In recent decades many new potential and effective drugs have been developed 
and, as a result, more and more diseases can now be adequately treated with 
drugs. However, the occurrence of adverse reactions may limit the effectiveness 
of drugs, and may even lead to significant morbidity and mortality rates and 
increased financial costs. Several studies have shown that adverse reactions can 
also result in hospital admission.[1-3] 
A number of adverse drug reactions that can be prevented are the cause of 
medication errors. Both in general practice and in hospitals, these preventable 
errors in the prescription of drugs have been shown to include errors in the 
choice of drugs, the dosage, the form of dosage or the dosage schedule.[4-8] 
 
Studies on preventable medication errors 
A recent literature review on the incidence of adverse drug reactions and 
outcomes related to preventable adverse drug reactions in hospitalised patients, 
showed that the median frequency of adverse drug reactions was 1.8%, with a 
range from 1.3% to 7.8%. The median preventability rate was 35.2%, with a range 
from 18.7% to 73.2%. Most of these adverse drug reactions occurred in the stage 
of drug prescription, and were dose-related. Inappropriate drug-prescribing and 
insufficient patient-monitoring were the most frequently identified causes of 
preventable adverse drug reactions.[9]  
In a prospective study performed at a teaching hospital in the UK the causes of 
prescribing errors were examined, and prescribers who made potentially serious 
errors were interviewed. The results of this study showed that most of the errors 
were made because of a lapse of attention or because prescribers did not apply 
the relevant rules. The doctors themselves also identified many risk factors, such 
as work environment, work-load, communication within their teams, physical and 
mental well-being and lack of knowledge. Other factors included inadequate 
training, low perceived importance of drug-prescribing, a hierarchical medical 
team and the absence of personal awareness of the errors. It was remarkable 
that senior house officers and junior house officers made the most errors. All 
major medical and surgical specialists were represented in this study.[8] 
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Irrational drug prescribing 
In addition to the occurrence of serious medication errors, resulting in severe 
side-effects or hospitalisation, there are also indications that irrational drug 
prescribing is a general problem in medical practice. Examples of this 
phenomenon include the prescription of drugs not related to the diagnosis, the 
prescription of relatively expensive drugs, irrational prescription of antibiotics 
and unnecessary continuation of drug treatment in the elderly, leading to 
polypharmacy.[10] 
 
Attempts to improve the quality of drug-prescription are partly successful 
In order to address the problem of irrational drug-prescribing and the occurrence 
of prescribing errors, several measures have been taken by medical organisations 
and governments. On the one hand, standards and guidelines for drug treatment 
have been developed and implemented in the continuing postgraduate medical 
education with the aim to improve drug-prescription. On the other hand, cost- 
saving measures have been implemented, for example through the 
reimbursement system. These measures have contributed to the improvement of 
the drug-prescription. However, despite these measures medical doctors do not 
easily change their practice routines including their drug-prescribing behaviour. 
Examples of reasons are lack of time in a busy practice, patient demands, and 
the subjective influence of the pharmaceutical industry.[11;12] 
 
Medical doctors may not be adequately trained in pharmacotherapy 
Another plausible explanation for the afore-mentioned phenomenon is that 
medical doctors have not been adequately trained in rational drug prescribing. 
[8;13] Education in clinical pharmacology and therapeutics is still not a core 
element in most medical curricula, and the drug prescribing competence of 
medical students has rarely been explicitly assessed.[14-16] In the Netherlands, 
this problem has been the subject of debates since the early nineties. In 1992 the 
first external review of the entire undergraduate medical training programme 
was initiated by the Association of Universities in the Netherlands (VSNU). It was 
concluded that the pharmacotherapy education was satisfactory in only two of 
the eight medical faculties.[17] In 1993, a committee consisting of pharmacology 
and pharmacotherapy teachers analysed the pharmacology and pharmacotherapy 
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training programmes of the medical faculties. The committee reached the 
conclusion that clinical pharmacology and pharmacotherapy education and 
assessment should be improved, although some positive developments had taken 
place.[18] After the second external programme review, in 1997, it was advised 
that the students should be involved in the prescription of drugs for patients 
during their clinical clerkships, and that their level of competence in choosing 
and prescribing drugs should be explicitly assessed.[19] It can be concluded that 
in medical doctors at the time of graduation, there were strong indications that 
the rationality of choosing and prescribing drugs was insufficient. This might well 
be an important cause for irrational prescription in daily practice.  
 
Overview of the medical curricula in the Netherlands in the early nineties 
The undergraduate medical curricula in all medical faculties in the Netherlands 
consisted in general of a pre-clinical phase of 4 years, followed by clinical 
clerkships for a period of 2 years. In the pre-clinical phase, students were taught 
the theory of anatomy, physiology, pathophysiology and clinical features, 
including pharmacology and the drugs used to treat the diseases of the organ 
systems. In most curricula the students, divided into small groups, learned to 
apply the previously gained knowledge to solve a patient’s medical problems. 
One can say that gaining knowledge, followed by learning to apply this 
knowledge is a form of sequential learning. After the pre-clinical phase, in 
almost all of the medical faculties, 5th year students began their clinical 
clerkships, starting with clinical skills training for a period of six weeks, which 
included training in pharmacotherapy skills. The training was followed by clinical 
clerkships of two to twelve weeks in all major clinical departments and in 
general practice so that the students learned to apply their knowledge in clinical 
practice. During the final clerkship, the students were gradually given more 
responsibility. One can say that both the pre-clinical phase and the clinical 
clerkships of the medical curricula were mainly based on sequential learning.  
 
Developments in medical education 
Since then, various changes have been made in the curricula in favour of 
confronting students with patient problems at an earlier stage in their study. All 
these changes are mainly based on the growing evidence that gaining knowledge 
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combined with applying knowledge, is more effective than sequential 
learning.[20] This is explained by theories originating from cognitive psychology 
and their application in medical problem-solving. The way in which knowledge is 
stored in the memory determines to a great extend the availability of the 
knowledge when it has to be recalled or applied. If the knowledge is gained 
simultaneously with solving patient problems, it will be stored in combination 
with the problems to which it has to be applied. When the student has to solve 
such patient problems, for example during a clinical examination or in clinical 
practice, the knowledge is recalled much more accurately and rapidly.[21;22] 
These theories are mainly based on studies of diagnostic problem-solving and 
form the basis of innovations in medical education. Compared to the traditional 
(sequential) method of education, students are confronted with patient problems 
in an earlier phase of their study. However, little is known about the effect of 
learning to solve pharmacotherapeutic patient problems simultaneously with 
gaining knowledge of pharmacology.  
 
Research project for the development of a pharmacotherapy curriculum 
Between 1995 and 2002, an educational research project was conducted at the 
VU Medical Centre Amsterdam in the Netherlands. The general aim was to 
evaluate the level of competence in pharmacotherapy of medical students 
nearing graduation, and to seek ways to improve it, if necessary. Competence is 
defined as what a person is capable of doing in an observed/examination setting. 
[23] With regard to pharmacotherapy, competence mainly consists of skills and 
attitudes. Four studies were conducted, and within the framework of this overall 
aim, the following research questions were formulated: 
1. What are the pharmacotherapy learning objectives of the undergraduate 
medical curriculum in the Netherlands? 
2. Do medical students nearing graduation meet the requirements defined in 
the learning objectives with regard to pharmacotherapy skills? 
3. Are pre-clinical students able to learn the cognitive pharmacotherapy 
skills simultaneously with gaining the necessary knowledge of 
pharmacology and pharmacotherapy? 
4. What is the effect of a longitudinal context-learning programme for 
pharmacotherapy skills on the level of competence of pre-clinical 2nd–4th 
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year medical students as well as on their level of therapeutic knowledge, 
the study-load and their appreciation of the programme? 
 
The first three studies were financial supported by grants from the Dutch Ministry 
of Public Health, Welfare, and Sports (VWS), the Dutch College of Insurance 
Companies (CVZ) and the Dutch Association of the Research-based 
Pharmaceutical Industry (Nefarma). The results of these studies have been 
reported to the financiers, but have not yet been published. Forming a part of 
this thesis, the reports have been rewritten in a scientific format (papers).  
 
Outline of this thesis 
Chapter 2 describes the findings of a national survey. In a literature survey the 
pharmacotherapy learning objectives of the undergraduate medical curriculum 
were identified. Subsequently, by applying a Delphi procedure, pharmacotherapy 
teachers reached maximum consensus on the required level of competence. 
Chapter 3 describes the results of a national survey, which was held to evaluate 
whether medical students nearing graduation met the requirements defined in 
the learning objectives for pharmacotherapy skills and the treatment of core 
diseases. Cognitive, communication and motor skills were distinguished. Chapter 
4 reports the results of a controlled intervention study. The study focused on 3rd 
year pre-clinical students in two medical faculties. Based on theories regarding 
(medical) education, these students received a short training in cognitive 
pharmacotherapy skills. Chapter 5 presents the results of the implementation of 
a context-learning programme for pharmacotherapy skills. The development of 
this programme was based on the results of the previous studies and modern 
insights into medical education. Between 1998 and 2001 the programme was 
gradually implemented in the curriculum of the VUmc for all pre-clinical 2nd-4th 
year medical students. In chapter 6 the General Discussion, the results are 
discussed more generally within the context of clinical competence/performance 
and the conceptual model of clinical context-learning. The implications of the 
findings for the development of educational programmes in pharmacotherapy are 
discussed, and recommendations are made for future education programmes and 
future research in this field. The thesis concludes with a summary in both English 
and Dutch.  
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Abstract 
Aim: To determine the pharmacotherapy learning objectives of the undergraduate 
medical curriculum in the Netherlands. 
Methods: A survey among all eight medical faculties in the Netherlands. By means of a 
literature survey all published pharmacotherapy learning objectives were identified. 
These objectives were combined and ordered into 135 specific and 27 general 
objectives. The specific learning objectives describe the diseases and symptoms that 
final year students should be able to treat, and the general learning objectives describe 
in general the knowledge, skills and attitudes which are relevant for treating these 
diseases and symptoms. The two lists of learning objectives were sent to the heads of 
the departments of relevant disciplines, who were responsible for the pharmacotherapy 
training, in all eight medical faculties. They individually indicated the level of 
competence students nearing graduation need to achieve to master the treatment of 
each disease mentioned in the specific learning objectives. They also indicated the 
relevance of the general learning objectives, i.e. the knowledge, skills and attitudes. 
Subsequently, a Delphi procedure was applied to reach maximum consensus between the 
respondents.  
Results: The required level of competence for 68 diseases and symptoms is the highest 
level: ability to choose and perform the drug treatment for any patient independently 
and according to the professional standard. For 37 diseases the required level is: ‘ability 
to choose the treatment’, and for 9 diseases ‘knowledge of the drugs which are relevant 
for the treatment’. For the ability to treat patients with these diseases medical students 
should, in particular, have sufficient knowledge of the basic principles of pharmacology 
and clinical pharmacology, master all relevant cognitive, communication and motor 
skills, and should also have a critical attitude towards disturbing influences which might 
cause irrational drug-prescribing.  
Conclusions: The core of the learning objectives consists of 68 core diseases. To be able 
to treat any patient with a core disease, medical students should master all relevant 
pharmacotherapy skills at the highest possible level: have sufficient knowledge of 
pharmacology, and a critical attitude towards irrational drug-prescribing.  
Vollebregt JA, Metz JCM, Haan de M, Hugtenburg JG, Vries de TPGM. Learning objectives for 
undergraduate pharmacotherapy knowledge, skills and attitudes; a national survey. Submitted. 
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Introduction 
Irrational drug prescribing seems to be a general problem in medical practice. 
Examples of this problem are the prescription of drugs that are not related to the 
diagnosis, the prescription of relatively expensive drugs, irrational prescription of 
antibiotics and unnecessary continuation of drug treatment in the elderly leading 
to polypharmacy. [1;2] In addition, it has been shown that both in general 
practice and in hospitals preventable errors are made in the prescription of 
drugs, such as errors in the choice of the drug, the dosage, the form of the 
dosage form or the dosage schedule. [3-6]  
Irrational and expensive drug prescribing still occurs, despite the development of 
standards and guidelines for drug treatment, continuing medical education for 
doctors and cost-saving measures taken by governments. [1] This indicates that 
medical doctors do not easily change their drug-prescribing behaviour, due to 
various factors such as lack of time in a busy practice, patient demands and the 
subjective influence of the pharmaceutical industry. [7]  
Another possible explanation is that these doctors have not, or have been 
inadequately taught how to prescribe drugs rationally. For example, there are 
indications that there is insufficient undergraduate training in clinical 
pharmacology and therapeutics. Unlike diagnostics, education in clinical 
pharmacology and therapeutics is still not a core element in most curricula, and 
the drug-prescribing competence of medical students has rarely been explicitly 
assessed. [8-11] Therefore, the level of competence with regard to the choice and 
prescription of drugs of medical doctors at the time of graduation was unknown, 
and it was also unknown whether medical doctors have been adequately trained 
to deal with the factors that cause irrational drug-prescribing in daily practice. 
The aim of this study was to determine the pharmacotherapy learning objectives 
that medical students have to achieve at the time of graduation in the 
Netherlands. These learning objectives serve as a standard for the measurements 
described in the following three chapters of this thesis (chapter 3-5). 
 
Method 
Outline 
By means of a literature survey, all published pharmacotherapy learning 
objectives were identified. Subsequently, two questionnaires containing a 
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selection of these objectives were sent to the heads of the departments of 
relevant disciplines, who were responsible for the pharmacotherapy training, in 
all eight medical faculties in the Netherlands. They individually indicated the 
level of competence students nearing graduation need to master the treatment 
of each disease mentioned in the specific learning objectives. They also 
indicated the relevance of the general learning objectives, i.e. the knowledge, 
skills and attitudes. A Delphi procedure was then applied to reach maximum 
consensus between the respondents. 
 
Literature 
In order to identify publications regarding learning objectives in therapeutics for 
the entire undergraduate medical curriculum, a survey of the literature 
published between 1980 and 1996 was performed in Medline. The following text 
words were used: ‘curriculum’, ‘therapeutics OR pharmacotherapy’, ‘education 
AND students’. The search revealed 15 publications. [9;12-25] These publications 
also included three references through which a total of 18 publications were 
retrieved. [8;26;27] Two Dutch publications, found on personal title of the main 
researchers, were also included. [28;29] 
In 14 publications elements of the medical curriculum or the effect of training 
methods are described. The remaining 6 publications describe the learning 
objectives for therapeutics for the entire undergraduate curriculum as well as 
the learning objectives for pharmacotherapy knowledge, skills and 
attitudes.[9;19;20;23;28;29] In 1990, a list of the core knowledge, skills and attitudes 
that every medical student should master before graduation was developed in 
the United States. [19;20] The list was based on consensus achieved between 40 
clinical pharmacology teachers. All learning objectives were rated as equally 
important, and no distinction was made between the levels of mastery. In 1994, 
a questionnaire was developed in the United Kingdom, based on these learning 
objectives. [24] Clinical pharmacologists in 27 medical faculties were asked to 
rate on a 4-point scale the relative importance of each learning objective as 
element of a core curriculum. Core knowledge items were rated as important or 
very important, whereas core skills were rated as less important and core 
attitudes were of intermediate importance.  
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In 1993 the necessary cognitive skills for the choice and prescription of a drug 
treatment (table 2: 2.1–2.9) were formulated in the Netherlands. [30] A 
committee of Dutch pharmacotherapy teachers from all eight medical faculties 
incorporated the list of cognitive skills into a list of learning objectives, 
consisting of knowledge, skills (cognitive, communication and motor skills) and 
attitudes with regard to pharmacotherapy. [28] The World Health Organisation 
(WHO) used the list of cognitive skills to describe the process of therapeutic 
clinical reasoning. [31] In 1994, a list of the learning objectives for the entire 
undergraduate medical curriculum in the Netherlands including (pharmaco) 
therapy, was published, in collaboration with the Disciplinary Board for Medical 
Sciences of the Association of Universities in the Netherlands (in which all the 
Deans are represented), the Royal Dutch Medical Association, and the Ministry of 
Health, Welfare, and Sports. [29] In the so called ‘Blueprint’ the learning 
objectives are subdivided into specific (discipline-related) and general 
objectives. The specific objectives are listed according to the medical disciplines 
and consist of diseases and symptoms. A doctor must be able to treat 216 
diseases and symptoms in clinical practice at a certain level: make the diagnosis 
personally or carry out the therapy personally, referring to the most common 
therapy for an uncomplicated illness. The general objectives describe the 
knowledge, skills and attitudes for mastering these tasks. Consensus among 
representatives of all collaborating institutes was achieved in the formulation of 
both discipline-related and general objectives.  
 
Questionnaires 
In 1995, two questionnaires were developed on the basis of the literature survey. 
The first questionnaire contained a list with specific learning objectives and the 
second contained the general learning objectives (see Tables 1 and 2; left hand 
column). It was decided to emphasise the process of therapeutic problem-solving 
in the description of the learning objectives and to relate these as closely as 
possible to the previously developed learning objectives in the Netherlands. [29] 
Therefore both lists were based on the Blueprint. In the Blueprint, 216 diseases 
and symptoms are described at the level of ‘ability to carry out the therapy 
personally, referring to the most common therapy for an uncomplicated illness’. 
After omitting all diseases and symptoms with non-drug treatment, such as 
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surgery, the remaining 135 diseases and symptoms were classified according to 
the clinical disciplines. 
A total of 20 pharmacotherapy general learning objectives were taken over from 
the Blueprint. Based on the classification of the American Council for Medical 
Student Education in Clinical Pharmacology and Therapeutics, these learning 
objectives were classified into three categories: knowledge (and understanding), 
skills (cognitive, communication, motor skills), and attitudes. [19] Three 
conditions from another Dutch publication were added: ‘knowledge and 
understanding of clinical pharmacology’ (1.2 in table 2), ‘consider the individual 
aspects of each prescription’ (6.2), ‘maximise efficacy, safety, compliance’ 
(6.3). [28] Four derived cognitive skills (5.1 - 5.4) were added by the 
investigators, because reference materials and clinical guidelines are gradually 
becoming more widely used (obligatory).  
 
Survey 
The two questionnaires were sent to the heads of the Departments of Clinical 
Pharmacology, Internal Medicine and General Practice in all eight medical 
faculties. These departments are responsible for almost all the undergraduate 
therapeutic training in the Netherlands.  
In the first questionnaire concerning the specific learning objectives, the 
respondents were asked to indicate on a 4-point scale the level of competence 
needed by graduated medical doctors to master the drug treatment for each 
disease or symptom (3: highest level to 0: lowest level). Level 3 was defined as 
ability to choose and prescribe a drug treatment independently and 
professionally for any patient with the disease, level 2 as ability to choose a 
(standard) drug treatment for the disease, level 1 as knowledge of the drugs that 
can be used for treatment of the disease, and level 0 as no need to know the 
drugs that can be used for treatment of the disease. Level 3 indicates that 
graduates should be able to treat patients with these diseases at the start of the 
postgraduate specialisation, also because they are then legally licensed to 
prescribe drugs. Level 2 indicates that actual prescription of the drug still has to 
be learned during the postgraduate specialisation. Level 1 indicates that patients 
with the disease should be referred to a specialist for the drug treatment, and 
level 0 indicates a disease that requires superior specialist treatment.  
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The general objectives describe the knowledge, skills and attitudes that are 
necessary for a doctor to provide adequate pharmacotherapeutic care. In the 
undergraduate medical education an initial effort is made to achieve the goals. 
Instead of indicating the required levels for each general objective, the 
respondents were asked to indicate on a 3-point scale the relevance of the 
conditions for mastering drug treatment: (2) undoubtedly relevant, (1) rather 
relevant, (0) not relevant. Finally, the respondents were asked to add and score 
any relevant learning objective that was not included in both lists. 
 
Delphi procedure 
After the respondents had returned the questionnaires, a Delphi procedure was 
applied to reach maximum consensus about the required level for each objective 
on both lists. The Delphi procedure is a method used to increase agreement on 
an issue in several subsequent rounds. It has been proven to be successful in 
research on medical education as well as on clinical practice. [32;33] In the first 
round, for each (specific and general) learning objective the respondents scored 
according to the level that was required in their department. In a second round, 
the respondents were informed about their own initial score for each learning 
objective, the average score, and the score-range of the whole group. They were 
then asked whether they would change their score, knowing the total group 
response. In the third round this was repeated again. Subsequently agreement on 
the level of competence for each learning objective was calculated by a 
described kappa coefficient for categorical data. Consensus was reached if the 
agreement was at least 0.61. [34] 
 
Results 
All respondents completed both questionnaires and no additional learning 
objectives were suggested. Two respondents from two different medical faculties 
did not take part in the second and third round of the Delphi procedure. The 
results of the questionnaire concerning the specific objectives are presented in 
Table 1.  
  
Table 1. Specific pharmacotherapy learning objectives. For 135 diseases the required level of competence in mastering the drug treatment is presented:  
3= to choose and prescribe a drug treatment independently and professionally for any patient with the disease 
2= to choose a (standard) drug treatment for the disease 
1= knowledge about the drugs that can be used for treatment of the disease 
0= no need to know the drugs that can be used for treatment of the disease.  
In case of full agreement after the Delphi procedure (kappa coefficient >0.61) only the mode is presented; 
in case of disagreement the range is also presented between brackets. 
 
Cardiovascular disorders Level Genitourinary tract Level Endocrinology, impaired metabolism Level 
Angina pectoris  3  Genital herpes 3  Diabetes non-insulin-dependent (type II)  3 
Acute myocardial infarction 3  Renal colic 3  Hypoglycaemia 3 
Cardiac asthma 3  Cystitis 3  Acute gout  3 
Hypertension uncomplicated 3  Urethritis 3  Hyperthyreoidism 2 
Thrombophlebitis 3 (2-3) Vaginitis, candidiasis  3  Hypothyreoidism 2 
Cardiac failure 2  Vaginitis, trichomoniasis 3  Hypercholesterolemia 2 
Shock: acute treatment 2  Vaginitis, gardnerella 3  Diabetes insulin-dependent (type I)  2 
Deep vein thrombosis 2  Vaginitis, non-specific bacterial 3  Infections and parasitosis  
Intermittent claudication  2  Vaginitis, atrophic 3  Erysipelas 3  
Supraventricular dysrhythmia 1 Contraception 3  Folliculitis 3  
Conduction defect 1 Pyelonephritis 2  Herpes simplex  3  
Postural hypotension 1 (0-2) Prostatitis 2  Pediculosis capitis and pubis 3  
Arteritis temporalis 1 (0-2) Dysmenorrhoea 2  Flea bites 3  
Pulmonary embolism 1  Premenstrual tension syndrome 2 (1-3) Pityriasis versicolor 3 (1-3) 
Accidents Level Nephrotic syndrome 1  Candidiasis of the skin and nails 2 
Insect bite 3  Musculoskeletal system and connective tissue Scabies 2 
Motion sickness 3  Osteoarthrosis deformans 3  Herpes zoster 2 
Allergy due to medication in proper dose 3  Myalgia (muscle pain) 3  Acute gonorrhoea, sexually transmitted 2 
Anaphylaxis due to medication 3  Lumbar backache / low back pain 3  Chlamydia, sexually transmitted  2 
Carbon monoxide poisoning 3 (1-3) Rheumatoid arthritis 2  Syphilis, primairy genital 2  
Drug poisoning  2 (1-3) Olecranon bursitis 2  Enterobiasis 2 (1-3) 
Heroin overdose 2 (1-3) Osteoporosis prevention 2  Molluscum contagiosum 2 (1-3) 
Alcohol overdose 2  Osteoporosis management 2 (1-3) Salmonellosis gastroenteritis  2 (1-3) 
  Tendovaginitis 2 (1-3)   
  
  
   
Haematological disorders Level Symptoms Level Nervous system and sense organs Level 
Iron deficiency anaemia 3 Cough 3  Otitis externa 3 
Macrocytic anaemia (pernicious) 3 (1-3) Nausea and vomiting 3  Acute otitis media  3 
Gastrointestinal disorders Sleep disturbance 3 Furuncle of nose 3 
Herpes labialis 3  Pain of low intensity 3  Conjunctivitis 3 
Candidiasis of mouth/throat 3  Tension headache 3  Blepharitis 2 
Gastritis  3  Febrile convulsion 3  Status epilepticus 2 
Peptic ulcer 3  Pain of high intensity 2 (2-3) Migraine 2 
Irritable bowel sydrome  3  Feeling anxious / nervous / tense  2  Vertigo: Ménière’s disease 2 
Constipation 3  Diseases of skin and subcutaneous tissue Herpes zoster oticus 2 (1-3) 
Diarrhea: dehydration 3  Impetigo (vulgaris) 3 Dacryocystitis 1  
Diarrhea: symptomatic 3  Furuncles 3 Keratitis 1  
Glossitis 2 Acne (vulgaris) 3 Iridocyclitis 1 
Reflux oesophagitis 2 Warts 3 Acute glaucoma  1  
Cholelithiasis 2  Mycosis 3 Respiratory disorders  
Obesity 2 (1-3) Seborrhoeic eczema 3 Pneumonia 3 
Stomatitis 2 (1-3) Napkin eczema 3 Common cold  3 
Crohn’s disease and ulcerative colitis  1 Urticaria 3 Hay fever (allergic rhinitis) 3 
Child bearing and neonatal period  Itching (pruritis) 3 Maxillary sinusitis acute 3 
Puerperal mastitis 2  Cellulitis 2 Tonsillitis acute  3  
Cracked nipple  2  Atopic / constitutional eczema 2 Pharyngitis acute 3  
Level 2 Dyshidrotic eczema (intertrigo) 2 Subglottic laryngitis 3 
Neonatal conjunctivitis 2  Hydradenitis supporativa 2 (1-3) Acute laryngo-tracheitis 3 
  Erythema chronica migrans 1 (1-3) Acute bronchitis 3 
    Chronic bronchitis 3 
    Asthma: acute exacerbation 3 
    Asthma: management of stable disease 2 (2-3) 
    Lung emphysema 2 
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Table 2. General pharmacotherapy learning objectives. For 28 conditions concerning knowledge 
and understanding, skills and attitudes the relevance for mastering drug treatment is presented:  
2= undoubtedly relevant, 1= rather relevant, 0= not relevant.  
In case of full agreement after a Delphi procedure (kappa coefficient >0.61) only the mode is 
presented; in case of disagreement the range is also presented between brackets.  
 
  Level  
1. Knowledge & Understanding  
1.1: Basic principles of pharmacology 2 
1.2: Clinical pharmacology 2 
1.3: Practical aspects of prescribing drugs 2 (1-2) 
1.4: Costs of prescribing drugs 1 
1.5: Disturbing influences on prescription behaviour  1 
   
2. Cognitive Skills  
2.1: Determine the goal(s) of treatment for the individual patient, taking all patient and disease characteristics into account 2 
2.2: Consider drug treatment versus non-drug treatment for the individual patient, taking all patient and disease characteristics into account 2 
2.3: Choose a (drug)treatment for the individual patient, taking all patient and disease characteristics into account 2 
2.4: Choose dosage form, dosage and duration of treatment for the individual patient, taking all patient- and disease characteristics into account 2 
2.5: Determine the patient information about the treatment 2 
2.6: Determine the instructions for using the drug 2 (1-2) 
2.7: Determine the time and content of evaluation of the treatment 2 
2.8: Draw conclusions on the basis of the evaluation 2 
2.9: Modify the treatment if necessary 2 
   
3. Communication Skills  
3.1: Inform and instruct the patient clearly about the treatment  2 
3.2: Verify that the patient understood the information 2 
3.3: Write a full prescription 2 
   
4. Motor Skills  
4.1: Prepare a drug for parenteral administration 1 
4.2: Administer a drug parenteral(ly)  2 (1-2) 
   
5. Derived Cognitive Skills  
5.1: The use of the Dutch National Formulary 2 
5.2: The use of Clinical Guidelines 2 (1-2)  
5.3: The use of Clinical Formularies 1 (1-2) 
5.4: The draft and use of a Personal Formulary 1 (1-2) 
   
6. Attitudes  
6.1: A critical attitude towards disturbing influences 2 
6.2: Consider the individual aspects of each prescription 1 (1-2) 
6.3: Maximise efficacy, safety, compliance 2 (1-2) 
6.4: Keep up-to-date about drugs and their developments 1 (1-2) 
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They show that for 68 diseases and symptoms the treatment should be mastered 
at the highest possible level: ability to choose and prescribe a drug treatment 
independently and professionally for any patient with the disease. For 37 
diseases and symptoms the required level is 2: ability to choose a (standard) drug 
treatment for the disease, and for 9 diseases this level is 1: knowledge of drugs 
that can be used for treatment of the disease. For the remaining 21 diseases and 
symptoms, no agreement could be reached on any of the four levels.  
The results of the questionnaire concerning the general learning objectives are 
presented in Table 2. For mastering drug treatment, it is considered to be 
undoubtedly relevant (level 2) to have sufficient knowledge of basic principles 
and clinical pharmacology, to master almost all cognitive, communication and 
motor skills, and to have a critical attitude towards disturbing influences. It is 
considered to be rather relevant (level 1) to have sufficient knowledge of the 
costs of prescribing drugs and of disturbing influences on prescription behaviour, 
and to master the motor skills for preparing a drug for parenteral administration. 
For the remaining 9 learning objectives no agreement could be reached for either 
level. 
 
Discussion 
It was the aim of this study to determine the pharmacotherapy learning 
objectives that medical students have to achieve at the time of their graduation, 
in order to develop a standard for the measurements described in the following 
three chapters of this thesis. 
The results show that 135 diseases and symptoms are specific learning objectives 
of which 68 are core diseases. When they graduate, medical students should be 
able to master the treatment of these core diseases and symptoms at the highest 
possible level: ability to choose and prescribe the drug treatment independently 
and professionally for any patient. They should therefore, in particular, have 
sufficient knowledge of the basic principles of pharmacology and clinical 
pharmacology, master all relevant cognitive, communication and motor skills, 
and should also have a critical attitude towards disturbing influences causing 
irrational drug-prescribing, the so-called general learning objectives. For the 
other 67 (135-68) diseases, for which drug treatment is available, graduates 
should mainly have sufficient knowledge of the drugs that can be used for the 
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treatment, in particular in order to refer a patient to a specialist for the 
treatment. 
 
Interpretation of the results 
Respondents to the questionnaire represented three medical disciplines from all 
eight medical faculties in the Netherlands. Therefore, the relevance of several 
disciplines, such as ophthalmology, dermatology, paediatrics and neurology might 
be underestimated. The respondents from General Practice were the generalists 
of the 1st line and the respondents from Clinical Pharmacology and Internal 
Medicine were the generalists of the 2nd line. The choice was based on weighing 
the possibility of response from all participants instead of representation from of 
all disciplines, since every participant was asked to complete the whole list in 
order to provide a complete overview. Secondly, the list of specific learning 
objectives was a selection and the participants were asked to add any relevant 
diseases that were not included. Although no suggestions were made, it is 
unknown whether any relevant diseases were missed. It can also be argued that 
the results might have been different if more Delphi rounds and a final meeting 
with all respondents had been held. [35] Calculation of Cohen’s kappa might 
underestimate the agreement in cases in which almost all of the respondents 
were of the same opinion. [36] In such cases the calculated proportion of 
expected agreement is unjustly high, and therefore the kappa of expected 
agreement might also be high, resulting in a coefficient that is low. The 
agreement between the respondents with regard to the level of the learning 
objectives was probably higher than presented in this study. On the other hand, 
one should also take into account the fact that maximum consensus is not 
necessarily the best outcome: “consensus is sometimes described as where 
everyone agrees what no one actually believes individually”. [37]  
In the interpretation of the results, the Dutch undergraduate and postgraduate 
medical training should be taken into account. At the time of this study (1995), 
in all eight medical faculties the undergraduate curriculum consisted of four 
years of pre-clinical training and two years of clinical training (clerkships). There 
were only slight variations in the pre-clinical training programmes, in most cases 
consisting of integrated block or thematic teaching and line/longitudinal training 
in problem-solving skills. In all medical faculties methods are currently being 
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developed to teach students how to solve patient problems during the pre-
clinical training. The clinical period is very similar in all the medical faculties. 
Most of the students start with a short period of clinical skills training 
(approximately six weeks), followed by clinical clerkships in various clinical 
departments according to a rotation scheme. Several medical faculties have a 
final general clerkship of four to six weeks, during which the student is given 
more responsibility, comparable with internships in English speaking countries. 
After graduation, all students become general or basic doctors. This means that 
they are licensed by law to treat patients, but only under supervision, until they 
have completed their postgraduate training in a clinical discipline or in general 
practice. Nevertheless, postgraduate trainees frequently prescribe drugs 
independently.  
This situation makes it somewhat difficult to determine the learning objectives 
for the undergraduate training. The learning objectives presented in this paper 
have been mainly based on the Blueprint for the entire undergraduate medical 
curriculum in the Netherlands, as discussed earlier. [29] These learning objectives 
are the entry requirements for any postgraduate training. Therefore they cover a 
wide range of diseases which final year medical students should be able to treat 
at a 'general level', taking into account various psychological and sociological 
circumstances.  
 
From 1996 until 2004, three papers on learning objectives for clinical 
pharmacology and therapeutics have been published. In addition to the relevance 
of general pharmacotherapy learning objectives, core diseases are also 
described.[38-40] There were no major differences compared with the learning 
objectives described in this study. 
 
Recommendations 
The specific and general learning objectives determined in the present study can 
be used for revision of the medical curriculum. If necessary, learning objectives 
can be adapted to the local situation in other countries based on the method 
described in this study. They can be also be used to determine sub-levels in 
elements of the undergraduate curriculum, as well as in the development of 
training methods, for example training in the process of therapeutic clinical 
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reasoning. Finally, the learning objectives can be used to assess the competence 
of final year medical students, and the competence of pre-clinical and clinical 
students. In this way, curricula can be evaluated and revised, if necessary.  
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Abstract 
Aim: To evaluate whether final year medical students in the Netherlands meet the 
requirements as defined in the final year learning objectives for pharmacotherapy with 
regard to cognitive, communication and motor skills. 
Methods: A survey among 80 final year medical students from all eight medical faculties 
in the Netherlands. The students took two tests: a Short Essay test (SE) and an Objective 
Structured Clinical Examination (OSCE). In the SE, three cognitive pharmacotherapy 
skills were assessed. For 27 written patient cases, presenting core diseases the students 
had to (1) choose the treatment, (2) determine the patient information or (3) take 
monitoring measurements. In the OSCE, based on eight patient cases, the same three 
cognitive skills were tested but communication and motor skills were also assessed. For 
eight standardized patients presenting core diseases, students had to choose the 
treatment, give the patient information and discuss monitoring measurements. In two 
cases they had to perform therapeutic motor skills by using dummies, e.g. preparing and 
injecting medication parenterally. The students were observed and scored directly by 
the observers. The three cognitive skills were assessed anonymously by independent 
experts from three medical disciplines of three universities: internal medicine, general 
practice and clinical pharmacology.  
Results: The mean scores of final year medical students for mastering the cognitive skills 
in the SE and the OSCE were respectively 56% and 61% of the required level. For 
communication and motor skills in the OSCE these scores were respectively 73% and 54%, 
of the required level. Therapeutic errors were made in a range of 19–84% for all 
performances. 
Conclusions: The final year medical students who participated to the tests did not 
sufficiently meet the requirements defined in the final year learning objectives for 
pharmacotherapy with regard to cognitive, communication and motor skills. The results 
of this study strengthened the opinion that in the Netherlands the undergraduate 
medical training in pharmacotherapy is inadequate. 
Vollebregt JA, Metz JCM, Haan de M, Hugtenburg JG, Vries de TPGM. The competence in 
pharmacotherapy of final year medical students in the Netherlands; a descriptive study. Submitted 
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Introduction 
After graduation, medical students generally start their career as qualified 
doctors. In most countries they are then legally permitted to prescribe drugs, 
though often under supervision while specialising during postgraduate training. 
However, little is known about the level of competence of final year medical 
students in choosing and prescribing drugs for patients, since this is usually 
assessed implicitly or theoretically during clinical examinations. Only a limited 
number of studies have investigated the drug prescribing behaviour of medical 
students nearing graduation.  
In the Netherlands the undergraduate medical training programmes are reviewed 
once every five years. A review committee of the Association of Universities in 
the Netherlands (VSNU) concluded in 1992, after visiting all the medical 
faculties, that pharmacotherapy education was insufficient in all medical 
curricula.[1] Five years later it was concluded that the emphasis of the education 
was on basic knowledge of pharmacology and drugs. More attention should be 
paid to the process of choosing and prescribing drugs, and the pharmacotherapy 
training during the clerkships should be related to actual patients problems.[2] In 
a study amongst final year medical students in the Netherlands in 1990, the score 
for three aspects of drug prescription (choice of drug, dosage and duration) for 
four diseases was 50% of the required maximum.[3] In another study, performed 
in Australia in 1999, it was investigated whether interns could prescribe drugs 
appropriately for patients with four common diseases, both at the start and at 
the end of the internship. At the beginning of the year at least two-thirds of the 
interns were prescribing 'inappropriately' for all diseases, but at the end of the 
year 75% were prescribing 'appropriately' for the four diseases.[4] Moreover, the 
results of a pilot study performed in the USA in 1998 showed that the knowledge 
and therapeutic skills concerning over the counter medicines of 20 medical 
students during their family medicine clerkship was 49% of the maximum.[5] The 
results of several recent studies also indicate that residents make mistakes in 
choosing drugs and forms of dosage, in calculating drug doses, and in providing 
patients with information and instructions about the prescribed drugs.[6-8] 
The above mentioned literature indicates that among medical students nearing 
graduation, the level of competence in choosing and prescribing drugs is not 
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sufficient. It was the aim of this study to evaluate the level of competence in 
pharmacotherapy of final year medical students in the Netherlands. Competence 
is defined as what a person is capable of doing in an observed/examination 
setting.[10;11] In particular it was investigated whether they met the requirements 
for pharmacotherapy skills and the treatment of core diseases defined in the 
final year pharmacotherapy learning objectives, which had been determined in 
our previous study.[9]  
 
Methods 
Outline of the study 
In 1996, 80 final year medical students from the eight medical faculties in the 
Netherlands were randomly selected to participate in two tests at the VU Medical 
Centre (VUmc) in Amsterdam. In a written Short Essay test (SE) their cognitive 
skills with respect to drug treatment were assessed and in an Objective 
Structured Clinical Examination (OSCE) cognitive, communication and motor skills 
with respect to drug treatment were tested on standardized patients.  
 
Population 
From each medical faculty, 10 students were allocated to participate in the 
study in the penultimate week of their clerkship in general practice. This was the 
final regular clerkship in seven out of the eight medical faculties; for the 
students from the medical faculty of Maastricht, it was planned halfway through 
their regular clerkships. The students took the tests during their return-day in 
the department of General Practice in June 1996. In most faculties the return-
group consisted of 10 students, but if there were more, a maximum of 10 
students were randomly allocated for participation by the local faculty. The 
participating students were not compared to the other students in their year-
class in any other way to determine whether the sample was representative. The 
students were informed in advance about the aim of the study, i.e. to assess 
their competence in pharmacotherapy. They also received instructions about the 
method of testing (SE, OSCE) and were told that they could use any reference 
materials they wished in both tests. They were not informed about the content 
of the tests. All 10 students of one faculty were tested on the same day, numbers 
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1-5 on the list started with the SE and numbers 6-10 with the OSCE. All 
participants received a small remuneration. 
 
Materials 
For 28 core diseases (Table 1) 28 written case-descriptions based on real patients 
were developed for both tests. The SE consisted of 27 cases, 7 of which were also 
used in the OSCE. One case was only used in the OSCE. The cases were selected 
according to the following criteria: pertaining to general practice, frequently 
occurring in clinical practice, incorporated in the list of 68 core diseases in the 
specific learning objectives and, if more diseases met these requirements, 
randomly chosen. [9] All cases were described on the basis of real patients from 
general practice and were carefully reviewed on content, wording and questions 
by two general practitioners, two specialists in internal medicine and two clinical 
pharmacologists. All cases had a standard design with regard to general patient 
information (e.g. age, gender, occupation and pregnancy), a summary of 
previous and current diseases and treatments (co-morbidity and medication), and 
an extensive description of the recent history, physical examination, results of 
physical and laboratory examinations, the diagnosis, and questions prompting for 
the essential elements of the case only. Of these cases, 15 were uncomplicated 
and 13 were complicated (Table 1). In complicated cases drug interactions, 
contraindications, pregnancy, breast-feeding or other complications were to be 
taken into consideration in the choice of treatment. In uncomplicated cases 
these factors were not present. For each case an answer key was formulated and 
carefully reviewed by the same experts who reviewed the cases. In addition to 
the specific information per case, general criteria were determined for the 
assessment of each cognitive skill.  
For the eight cases in the OSCE a patient role was also written, including 
instructions for standardised patients. Each of them was trained in playing the 
role of one of the eight cases. Three detailed scoring lists were developed (Table 
2; left hand column). The first list was for assessing the three cognitive skills: (1) 
choosing the (drug)treatment, (2) determining the patient information and (3) 
determining the monitoring measurements. The second list was for assessing the 
five communication skills: actually providing the information (1) explaining the 
effect of the drug(s) and (2) the side-effects, (3) giving instructions about the use 
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of the drugs, (4) verifying that the information is understood, and (5) giving the 
patient the opportunity to ask questions or to discuss the (drug)treatment. The 
third list was for assessing the two motor skills: (1) preparing a drug for 
parenteral administration, and (2) administering the drug parenterally. The 
patient roles and the scoring lists were carefully reviewed on content and 
wording by two general practitioners and two psychologists. During pilot sessions, 
the observers were trained in the use of the scoring lists and the standardized 
patients were trained in playing the role of a patient. 
 
Table 1. Diseases in the 28 patient cases (15 uncomplicated and 13 complicated) in the Short-
Essay test (SE), and the 8 patient cases (*) in the Objective Structured Clinical Examination 
(OSCE). Numbers indicate the skills assessed in the SE and OSCE: 1: choosing a treatment; 2: 
determining patient information; 3: determining monitoring measurements; 4: communication skills; 
5: motor skills. 
  
Diseases Skills  Skills 
Uncomplicated SE OSCE Complicated SE OSCE 
Acne 3  Acute otitis media 2  
Bronchial asthma * 1 1,2,3,4 Allergy due to medication 3  
Constipation 1  Anaemia, iron deficiency 1  
Contraception 3  Atopic eczema * 3 1,2,3,4 
Diarrhoea symptomatic 2  Cardiac asthma 1  
Erysipelas * 2 4,5 Cough 1  
Gout 3  Cystitis 1  
Herpes zoster 1  Endometritis 1  
Hypertension * 3 1,2,3,4 Hypoglycaemia 3  
Insect bite * (OSCE only)  4; 5 Pneumonia 1  
Pain: low intensity 2  Status epilepticus 1  
Reflux oesophagitis * 3 1,2,3,4 Trombophlebitis 2  
Sinusitis acute 1  Vaginitis, trichomoniasis * 2 1,2,3,4 
Sleep disturbance * 3 1,2,3,4    
Urticaria 1     
 
 
Tests 
At the start of the SE the five students received 27 case-descriptions. For 12 
cases their task was to choose a (drug)treatment (table 1) . For another 6 cases 
the (drug)treatment was presented and their task was to determine what to tell 
the patient about the prescribed (drug)treatment. For the remaining 9 cases also 
the (drug)treatment was also presented but their task was to determine the 
monitoring measurements for the prescribed (drug)treatment. The students had 
two hours to answer the questions, after which the assessment forms were 
collected. 
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Before the start of the OSCE each of the five students was placed in one of five 
consultation rooms. Eight case-descriptions were laid out on the desk in a certain 
order. Various materials were also present in each room for patient instruction 
(e.g. placebo inhalers) and for parental administration of drugs (syringes, 
needles, flasks, dummies). For six cases the tasks were: to choose the treatment, 
to determine the patient information and monitoring measures, to write a 
prescription if a drug treatment was chosen, and to provide the patient with the 
necessary information and instructions about the treatment. For two cases the 
task was to prepare a drug for parenteral administration, to administer the drug 
(to a dummy) and, in one of the cases, to provide the patient with information 
about self-administration of the drug. Outside the consultation rooms eight 
standardized patients were paired to eight observers (medical doctors).  
At the start of the OSCE the students had 5 minutes to read the first case-
description and to prepare themselves for the consultation. Five of the eight 
patient-observer couples were placed in front of a consultation room in such a 
way that the cases presented to the students matched those of the standardized 
patients and the observers. The three other couples were placed in a 'waiting 
room'. After the 5 minutes of preparation the couples entered the consultation 
rooms, and the students had 10 minutes in which to perform the task(s). The 
couples then left the consultation room, went to the next one and waited in 
front of it. The fifth couple went to the 'waiting room', and one couple from the 
'waiting room' went to the first consultation room. After the 5 minutes, the 
students were allowed for preparation, the couples again entered the respective 
consultation rooms. This was repeated until all the students had completed the 
tasks for the eight cases. Subsequently, the prescriptions made by the students 
and the assessment forms completed by the observers were collected. 
 
Scoring 
The answers in both the SE and the OSCE for the cognitive skill ‘choosing a 
(drug)treatment’ were scored by four clinical pharmacologists. For practical 
reasons each of them scored the answers of 25% of the students. Three general 
practitioners scored the answers of 33% of the students for the cognitive skill: 
‘determining patient information’ and another three general practitioners scored 
the answers of 33% of the students for the cognitive skill ‘determining monitoring 
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measurements’. The scores ranged from 0 to 3 (0=no or incorrect answer; 
1=disputable answer; 2=acceptable answer; 3= correct answer). The names of 
the students and the names of the medical faculties were masked and replaced 
by numbers for the scoring. 
During the OSCE, all five communication skills were scored by the observers 
directly. The scores for three of these skills (‘explaining the effect of the 
(drug)treatment’, ‘explaining the side-effects’, and ‘giving instructions about the 
treatment’) ranged from 0 to 3 (0=not given; 1=given but not understandable; 
2=given but only partly understandable; 3=given and fully understandable). The 
scores for the other two communication skills (‘verifying that the information 
was understood’ and ‘giving the patient opportunity to ask questions’) also 
ranged from 0 to 3 (0=not verified or given; 1=hardly verified or insufficiently 
given; 2=not explicitly verified or given; 3=explicitly verified or given).  
The two motor skills ‘preparing a drug for parenteral administration’ and 
‘administering a drug parenterally’ were scored by the observers directly during 
the OSCE on a 2-point scale: (0= no, or bad performance; 1=partly correct 
performance; 2=correct performance). For all cognitive, communication and 
motor skills, answers in the SE and performances in the OSCE that were scored as 
0 or 1 were considered to be therapeutic errors. 
 
Analysis 
Mean scores were calculated as a percentage of the required scores for 
graduation (100%). Percentages of therapeutic errors (score 0 or 1) were 
calculated as a percentage of the total number of answers or performances. The 
Pearson correlation coefficient was used to analyse the relationship between the 
score for the cognitive skills in the SE and the OSCE. The Student’s t-test was 
used to analyse differences between the SE cognitive skills score of the students 
who started with the SE and the students who started with the OSCE. P<0.05 was 
considered to be statistically significant.  
 
Results  
76 (95%) and 66 (83%) final year medical students completed the SE and the OSCE 
respectively; 10 students from the UMCU (Utrecht) did not arrive at the 
prearranged time, so they only completed the SE. The results of the SE and the 
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OSCE are presented in Table 2. The overall mean score for the three cognitive 
skills in the SE and the OSCE were 55.8% and 60.7% of the required score for 
graduation, respectively. There was a slight relationship between the scores for 
the cognitive skills in both tests (Pearson correlation coefficient: r=0.36, n=66, 
p<0.028). 
There were no significant differences between the scores of the students who 
started with the SE and those who started with the OSCE. 
In the OSCE the scores for 'choosing a treatment' and 'determining monitoring 
measures' were significantly higher than in the SE (72.6% vs 63.3% and 66.0% vs 
52.9%); for 'determining patient information' the score at the SE was significantly 
higher (43.6% vs 51.3%). 
The percentage of therapeutic errors for these skills was 27.7% for 
uncomplicated cases, and 50.4% for complicated cases in the SE and 37.6% and 
32.1% respectively, in the OSCE.  
With regard to the choice of drug in all cases (uncomplicated and complicated) in 
the SE, in 31.4% of the cases the wrong drug was chosen, in 18.6% the wrong 
form of dosage, in 29.1% the wrong dosage and in 30.0% the wrong number of 
drugs was prescribed. For the OSCE the figures were respectively 13.9% (drug 
choice), 20.0% (form of dosage), 26.5% (dosage) and 39.4% (number of drugs). 
Detailed information can be found in Table 2. 
The overall mean scores for communication and motor skills were 73.0% and 
53.5% of the required score for graduation, respectively. The percentages of 
therapeutic errors for these two skills were 18.6% and 84.1%, respectively.  
Between the students from the different universities, the range in the score of 
the SE was from 41.0% - 57.3% of the maximum, and for the OSCE from 56.7% - 
60.7% of the maximum. For all students the range in score was 35.4% - 77.2% for 
the SE and 46.7% - 80.0% for the OSCE.  
  
Table 2. Assessment of the competence in pharmacotherapy skills of 66 and 76 final year medical students in an Objective 
Structured Clinical Examination (OSCE) and a Short Essay test (SE). Presented are the mean scores and confidence 
intervals (CI) of the skills as a percentage of the required level for graduation. Also presented are the percentages of 
therapeutic errors (score 0-1) for the uncomplicated and complicated patient cases in both SE and OSCE. 
 
 Skills (Mean % (CI)) Therapeutic error (Mean %) 
   Uncomplicated / complicated cases 
PHARMACOTHERAPY SKILLS OSCE (n=66) SE (n=76) OSCE (n=66) SE (n=76) 
Cognitive skills (score 0-3) 60.7 (59.5-61.9)# 55.8 (54.7 – 56.9) 37.6 / 32.1 27.7 / 50.4 
Choosing a treatment 72.6 (71.4-73.8)# 63.3 (60.8 - 65.8) 36.5 / 27.9 15.5 / 55.0 
Determining patient information 43.6 (42.3-44.9) 51.3 (48.4 - 54.2) # 21.7 / 21.4 36.8 / 31.6 
Determining monitoring measurements 66.0 (64.7-67.3)# 52.9 (50.2 - 55.6) 54.6 / 46.9 30.7 / 64.5 
     
Communication skills (score 0-3) 73.0 (71.1-75.0)  18.6  
Giving information about effect of the treatment 74.0 (71.7-76.3)  24.0  
Giving information about side effects 62.7 (60.7-64.7)  36.1  
Giving instruction about the treatment 83.7 (82.0-85.4)  12.2  
Verifying that the patient understood the information 67.0 (66.1-67.9)  14.6  
Giving the patient opportunity to ask questions 77.6 (76.4-78.8)  6.0  
     
Motor skills (score 0-2) 53.5 (52.3-54.7)  84.1  
Preparing a drug for parenteral administration 58.0 (56.5-59.5)  83.5  
Administering the drug parenterally 49.0 (46.8-51.2)  84.6  
 
# = significant difference between OSCE and SE (p<0,05). 
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Discussion 
To our knowledge, the present study was the first in which the level of 
competence in pharmacotherapy skills among) medical students nearing 
graduation was extensively investigated. The results showed that in 1996 the 
participating students scored approximately 40%, 30% and 50% below the required 
level for graduation for pharmacotherapy cognitive, communication and motor 
skills, respectively, and that many therapeutic errors were made in complicated 
cases. These results should be interpreted with care, taking into account the 
generalisation of the results and the validity and reliability of the tests.  
 
Generalization, validity, reliability and feasibility 
A participation of 5% of the medical students who graduate annually was low. 
Although they were selected randomly from eight different medical faculties in 
the Netherlands, it may be questioned whether the results can be generalised. 
However, medical doctors cannot permit themselves to make errors in the 
treatment of patients, so the level of competence in pharmacotherapy skills of 
all medical students with regard to the core diseases, should be 100% on 
graduation. This also applies to the participating students.  
In general, the validity and reliability of the SE and the OSCE is considered to be 
relatively high, in particular in the assessment of skills.[12-14] To our knowledge 
there is no specific information available with regard to the validity and 
reliability of these tests for pharmacotherapy skills, i.e. cognitive, 
communication and motor skills. The validity and reliability depends, among 
other things, on the content and number of cases in the SE and in the OSCE, 
respectively. 
The following three aspects contributed to the validity of the two tests. First, 
with 27 carefully selected core diseases (40% of the specific learning objectives), 
the SE was considered to be a good reflection of the specific learning objectives. 
The inclusion of so many core diseases was possible on the basis of the so-called 
‘key-feature’ concept.[15;16] In each case only the most relevant cognitive skill 
was assessed, and therefore more cases could be incorporated. Secondly, the 
practical setting of the OSCE was similar to that in which the actual work was 
carried out by 6th year medical students in their clerkships. Finally, it has 
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recently been shown that the standardised procedure for writing the case-
descriptions for both the SE and the OSCE contributes to greater test validity.[17]  
The reliability of a test determines the extent to which the results can be 
generalised to the entire domain, and mainly depends on the length and content 
of the test and the reliability of the assessment.[13] In a test, only a part of the 
domain can be assessed, because otherwise the test would be very time-
consuming. Therefore, in a test the problem of case-specificity, i.e. the 
variability in a student’s performance across all cases, affects the reliability. In 
the present study the following favourable measures were taken to improve the 
reliability. The level of competence in pharmacotherapy was measured in a SE 
and an OSCE. These two tests were complementary to each other. The SE only 
assessed cognitive skills, whereas the OSCE assessed all skills.[14;18] Another 
contribution to reliability was the inclusion of many cases as possible, based on 
the key-feature concept, in order to reduce the case-specificity.[19;20] 
Unfortunately, the reliability of the scores is unknown, since it was not possible 
to investigate whether there were differences in scores between the assessors 
(inter-rater agreement) and differences in two separate scores made by the same 
assessor (intra-rater agreement). The assessors of the SE were volunteers, and 
therefore a time consuming second assessment was not performed. Instead, it 
was decided to involve 10 different assessors in the assessment of all students, 
and each student was assessed by at least three assessors. The eight assessors of 
the OSCE each observed a station instead of having two assessors to observe four 
stations, since the reliability of the OSCE is improved including more stations 
instead of more assessors for each station.[13]  
With regard to the feasibility, there were several restrictions. The students had 
to travel to the VUmc and therefore 4 hours was the maximum time for the tests. 
For financial reasons the number of students from each medical faculty was 
limited to 10. If more students had participated, more standardized patients 
would be needed for the OSCE at greater expense. Finally, assessment of the 
cognitive skills of 80 students already was an enormous task.  
 
Remarkable findings 
Two remarkable findings will be discussed below. The first is that with regard to 
the cognitive skill 'choosing a treatment' the students performed better in the 
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OSCE than in the SE. This may be due to the setting of the OSCE, which was more 
similar to real clinical practice than the written SE. After all, these final year 
medical students had just finished working for two years in clinical practice 
during their clerkships. This is supported by the finding that the scores for the 
communication skills in the OSCE were rather high (average 73.0%) and the 
percentage of therapeutic errors rather low (18.6%). The difference may also be 
caused by the fact that the OSCE contained six uncomplicated and two 
complicated patient cases whereas in the SE the ratio was 15:13.  
The second remarkable finding was that with regard to the cognitive skill ‘to 
determine what to tell the patient’ the students performed better in the SE than 
in the OSCE. In both tests the students could consult reference materials. There 
are two explanations for this finding. Firstly, in the SE the students were asked 
explicitly to write down what they would tell the patient. In the OSCE it was 
inherent in the communication, and not explicitly asked. Secondly, in the OSCE 
the students had to combine ‘determining what to tell the patient about the 
treatment’ with actually ‘giving information and instructions in understandable 
language’. The latter task was obviously more difficult because the students also 
had to make use of their communication skills. The result was that many students 
gave incorrect information to the patient in understandable language. 
 
Steps of therapeutic competence 
Both above-mentioned findings might indicate that there is, indeed, a difference 
between the following three steps of therapeutic competence: 'knowing the best 
treatment for the disease', 'knowing how to choose the best treatment for an 
individual patient with the disease', and 'actually choosing and prescribing the 
best treatment for a patient with the disease'. At first sight, the initial step 
appears to be simple: textbooks, formularies, compendia, drug committees, 
teachers, colleagues and many other sources provide information about the best 
treatment(s) for each disease. In principle, this information can be memorised 
and used in practice. However, at second sight this is less easy than it appears to 
be because these sources often suggest different treatments for the same 
disease. This is due to various factors, such as the availability of the treatment, 
the application of different selection criteria and the different values given to 
each criterion, personal clinical experience, influence from and dependency on 
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the pharmaceutical industry, budgets made available by governments and 
hospitals, and reimbursement by insurance companies. This is a hurdle that pre-
clinical medical students have to take when they start their clinical clerkships. 
They experience that the knowledge about treatment they have gained from 
books (if it has not been forgotten, as is frequently the case) is often different 
from the treatment that is prescribed in hospitals, outpatient clinics and general 
practice. Therefore, instead of 'knowing the best treatment for the disease', 
students should learn 'how to choose the best treatment for the disease'. In other 
words, they have to learn how to use the information that can be obtained from 
all the different sources mentioned above. The WHO enforces this in the student 
manual ‘Guide to Good Prescribing’ by describing how to select standard 
(drug)treatments and how to develop a 'personal formulary'.[21] This provides 
students with awareness of the cognitive process of selecting and choosing drugs 
and the relative value of selection criteria. This also explains to them why no 
golden standard treatment exists, and why standard treatments frequently differ 
and change.  
The manual also provides the basis for the second step: 'knowing how to choose 
the best treatment for an individual patient'. In general practice, patients cannot 
always be treated according to the standard treatment. In outpatient clinics and 
hospitals there are probably more complicated cases requiring other treatment 
than the standard treatment. Therefore students have to learn how to choose a 
treatment taking the patient’s personal and clinical characteristics into account.  
This is especially important because in daily practice they will have to master the 
third step: 'actually prescribing the treatment for a patient with the disease'. 
Then they will have to combine the cognitive process of choosing the treatment 
with communication and negotiation with the patient about the treatment.  
 
Conclusion and recommendations 
Despite the limitations and considerations mentioned above, the results of this 
study strengthen the opinion that in 1996 the competence of medical students 
nearing graduation in the Netherlands did not meet the requirements defined in 
the final year learning objectives with regard to pharmacotherapy skills. It has 
been argued that inadequate undergraduate teaching was probably one of the 
reasons. Too much emphasis was laid on 'learning what (drug)treatment to 
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prescribe' instead of 'learning how to choose and prescribe a (drug)treatment'. 
Based on the results of this survey, it was recommended to develop, implement 
and evaluate new ways of teaching and learning pharmacotherapy. Training in 
choosing and prescribing (drug)treatments simultaneously with gaining factual 
knowledge about drugs and non-drug treatments, might contribute to a higher 
level of competence in pharmacotherapy skills, in particular during the pre-
clinical period. This would enable students to use the knowledge immediately 
within the context in which it has to be applied: choosing and prescribing (non-) 
drug treatments for individual patients. It has been shown that in diagnostic 
problem-solving this way of integrated learning is more effective than so-called 
sequential learning when knowledge is learned first and later applied.[22-24] It is 
recommended that this teaching method should be followed by explicit training 
and experience in choosing and prescribing drugs in a clinical setting, including 
frequent monitoring, supervision and feedback from staff members.  
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Abstract 
Aim: To determine whether pre-clinical medical students are able to learn cognitive 
pharmacotherapy skills, i.e. choosing a (drug) treatment, determining patient 
information and taking monitoring measurements, simultaneously with gaining the 
necessary pharmacology and pharmacotherapy knowledge. 
Methods: A controlled study based on a pre-test/post-test design among 85 3rd year pre-
clinical medical students from two medical faculties in Amsterdam. The students were 
randomly divided into a study group and a control group. The intervention programme 
was a copy of the obligatory training in pharmacotherapy skills for 5th year students. 
Before and immediately after the training both the study group and the control group 
took a test, and nine months later they took another test. In the tests the level of 
knowledge, and cognitive skills (choosing a [drug] treatment, determining patient 
information and monitoring measurements) were assessed. As a reference group the 5th 
year students also took the tests.  
Results: Before the training there was no difference between the levels of the cognitive 
skills in the 3rd year study group and control group: 26.7% and 27.4% of the required level 
for graduation, respectively. Immediately after the training the level in the study group 
had increased significantly (46.0%), and showed no significant decline on the second 
post-test nine months later (41.3%). The control group scored significantly lower on 
these two post-tests: 36.7% and 36.3% respectively. There were no differences between 
the study group and the control group in the level of knowledge in any of the three tests 
(52.8/53.3%, 69.1/66.4% and 55.0/55.7% of the maximum respectively). 
The level of cognitive skills in the 5th year reference group before and after their 
obligatory training was 40.3% and 44.5%, respectively. The level of knowledge increased 
significantly from 48.8% of the maximum before the training to 68.0% after the training.  
Conclusions: Pre-clinical medical students seem to be able to learn pharmacotherapy 
cognitive skills simultaneously with gaining pharmacology and pharmacotherapy 
knowledge. Clinical students, who mainly gain knowledge of drugs during their pre-
clinical years, might experience problems with learning cognitive pharmacotherapy skills 
because this knowledge might have gone rusty since then.  
Vollebregt JA, Metz JCM, Haan de M, Hugtenburg JG, Vries de TPGM. The ability of pre-clinical 
students to learn cognitive pharmacotherapy skills; a controlled trial. Submitted. 
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Introduction 
It is generally believed that applying knowledge, for example, in problem-solving 
is almost impossible if this knowledge has not yet been acquired. Therefore, 
most curricula start with a period of gaining knowledge, followed by a period of 
learning to apply this knowledge. The rather sharp distinction between the pre-
clinical and the clinical phase is also a reflection of this so-called sequential 
learning. More specifically, this is illustrated by teaching the basic principles of 
pharmacology and properties of drugs in the pre-clinical phase, followed by 
training in the choice and prescription of drugs in the clinical phase.  
However, in recent decades various changes have been implemented in the 
curricula of primary and secondary schools, universities, and consequently 
medical faculties. These changes vary considerably. In some medical faculties 
the teaching of clinical subjects has been moved to an earlier stage in the 
curriculum, and pre-clinical subjects postponed until the clinical years, for 
example a course in clinical pharmacology during the final clinical year. In other 
faculties the curriculum integrates pre-clinical teaching of basic and clinical 
subjects, longitudinal teaching of problem-solving simultaneously with gaining 
knowledge. Other curricula are complete problem-based like the medical 
curricula of McMaster University in Canada, and the University of Maastricht in 
the Netherlands).  
All these changes are mainly based on the growing evidence that gaining 
knowledge along with applying knowledge is more effective than sequential 
learning.[1;2] The greater effectiveness of gaining knowledge simultaneously with 
learning to apply the knowledge, is explained by theories originating from 
cognitive psychology and medical problem-solving.[3-6] The way knowledge is 
stored in the memory determines to a great extend the availability of the 
knowledge when it has to be recalled or applied. If the knowledge is gained 
simultaneously with solving patient problems, it will be stored in combination 
with the problems for which it has to be applied. When the student has to solve 
such patient problems, for example in clinical practice or in a clinical 
examination, the knowledge is recalled much more accurately and rapidly.[7]  
Theories of cognitive psychology explain this by showing that (diagnostic) 
problem-solving is mainly based on recognition of previous experience of cases 
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which are similar.[1] By frequently solving problems, doctors gradually generate 
so-called networks of organised knowledge in their memory. More exposure to 
patients and thus increasing experience, leads to condensation of these 
networks into easily accessible (illness) scripts. These scripts contain clinically 
relevant information about diseases, their consequences, and the context under 
which they develop. Then, based on recognition, the doctors are able to choose 
the right script for solving a specific problem efficiently.[5] These theories are 
based on studies of mainly diagnostic problem-solving. However, little is known 
about the effect on pre-clinical students of simultaneously learning therapeutic 
problem-solving and gaining pharmacology knowledge. 
Therefore, it was the aim of the present study to determine, in a controlled 
intervention study, whether pre-clinical students are able to learn the cognitive 
pharmacotherapy skills, i.e. choosing a (drug) treatment, determining patient 
information and determining monitoring measurements, simultaneously with 
gaining the necessary pharmacology and pharmacotherapy knowledge. 
 
Methods 
Study design 
A controlled intervention study with a pre-test/post-test design was performed. 
In addition to the normal sequential learning programme, a study group of 3rd 
year pre-clinical medical students received the same training in cognitive 
pharmacotherapy skills as 5th year clinical students. Before (T0), immediately 
after (T1) and again nine months after the training (T2) their pharmacology and 
pharmacotherapy knowledge and cognitive pharmacotherapy skills were tested. A 
control group of 3rd year students only participated in the tests. A reference 
group of 5th year clinical students took the same tests before and immediately 
after their obligatory training (T0,T1). 
 
Population  
In 1997, 90 3rd year medical students (45 students from the both VUmc and 45 
students from the AMC-UvA) participated voluntarily in the study in return for a 
small remuneration. The students were recruited by announcements and calls 
after lectures. Only students who had passed the 2nd year examinations were 
included. The scores of the participating students from the VUmc were compared 
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to those of the rest of their class on the pharmacology examination to determine 
whether the volunteers were comparable to their peers. The mean score of the 
participating students did not differ from that of the other 3rd year students. 
Unfortunately, no such data were available for the students from the AMC-UvA.  
All students were informed in advance about the aim of the study and the 
method of testing. They were allowed to use their own reference materials 
during the tests. After the pre-test (T0), based on the preliminary results of the 
knowledge test, a stratified randomisation (high, moderate and low score) of the 
90 students took place. 45 Students were allocated to the study group, and 45 to 
the control group. ‘Cross-contamination’ of the students in the study group and 
the control group was prevented by giving the students in the control group the 
opportunity to participate in the training after T2, and by explaining the 
importance of not exchanging any information. The students in the study group 
from both universities were sub-divided into two small groups, 11 students in 
each VUmc group and 11 and 12 students in the AMC-UvA groups. At each 
university the two groups received the training from one clinical pharmacologist.  
For the reference group of 5th year students the training was obligatory during 
their first clerkship (15 students at the VUmc and 23 students at the AMC-UvA). 
Therefore, it was not possible to create a control group. 
 
Undergraduate medical curriculum of participating universities 
In both medical faculties the undergraduate medical curriculum was very similar, 
and based on sequential learning. It consisted of a pre-clinical phase of four 
years, followed by clinical clerkships for two years. The pre-clinical phase mainly 
consisted of thematic blocks regarding certain organ systems. In each block the 
students were taught knowledge of anatomy, physiology, pathophysiology and 
clinical features, including pharmacology and the drugs to treat the diseases of 
that system. Simultaneously, in about 10% of the total study-load, the students 
learned in small groups to apply the previously gained knowledge to solve patient 
problems. During this problem-solving training the emphasis in the 1st and 2nd 
year was on history-taking and physical examination, and in the 3rd year on 
additional tests, such as X-rays and laboratory analysis, respectively. In the 4th 
year the emphasis was on therapy, including pharmacotherapy. 
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After the pre-clinical years the 5th year students entered the 2-year clinical 
clerkships, starting with a 6 weeks clinical skills training, including therapeutic 
skills. A copy of this training was used for the intervention in the 3rd year (see 
below). The clinical skills training was followed by clinical clerkships of two to 
twelve weeks at all major clinical departments and in general practice. 
 
Training (intervention) 
The training programme consisted of four plenary sessions of two hours a week, 
and approximately two hours of self-study each week. Before the start of the 
programme, but after the pre-test (T0), the students in the study group were 
provided with information about the learning objectives, treatment guidelines 
for four core diseases (essential hypertension, pneumonia, bronchial asthma and 
diabetes non-insulin-dependent (type 2)), the Dutch National Formulary, four 
written case-descriptions on the basis of real patient problems for each core 
disease, and with the World Health Organisation (WHO) Guide to Good 
Prescribing. [8] The four core diseases are included in the final year specific 
learning objectives. [9]  
The general learning objectives were: the ability to choose a (drug)treatment, to 
determine patient information about the (drug) treatment and to determine 
monitoring measurements for evaluating the effect of the (drug) treatment.  
The treatment guidelines were derived from the Dutch College of General 
Practitioners and from other sources [10-13]. The Dutch National Formulary 
contains relevant information about all the drugs that are available in the 
Netherlands, including advice on the choice of drug(s) for a certain disease.  
For each of the four core diseases four written case-descriptions were 
formulated according to a standard design: general patient information (e.g. age, 
gender, occupation and pregnancy), a summary of previous and current diseases 
and treatments (co-morbidity and medication), and an extensive description of 
recent history, physical examination, results of physical and laboratory 
examinations and the diagnosis. For each disease the cases differed with regard 
to the seriousness of the disease and complications such as age, co-morbidity and 
medication, drug allergy, pregnancy, and breast-feeding. 
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The WHO Guide to Good Prescribing provides medical students with a six-step 
approach to pharmacotherapy. These steps are:  
• (1) define the patient’s problem 
• (2) specify the therapeutic objective 
• (3) choose a (drug) treatment, taking all relevant patient characteristics 
into account  
• (4) start the treatment and/or write the prescription in case of a drug 
treatment  
• (5) give patient information and warnings 
• (6) take monitoring measurements.  
One of the key principles of the WHO approach is to divide step 3 into two parts: 
first consider your p-(drug) treatment (Personal (drug) treatment choice) for the 
disease in general (step 3a), and then verify its suitability for the patient in 
question and alter the (drug)treatment if necessary (step 3b). For determining 
the p-(drug) treatment the Guide also provides a step-by-step approach: (1) 
define the diagnosis, (2) specify the therapeutic objective, (3) make an inventory 
of effective groups of drugs, (4) choose an effective group according to criteria, 
(5) choose a p-drug. Finally, one or more p-drugs can be incorporated into p-
treatments.  
 
Before the first session the students had to read the WHO Guide to Good 
Prescribing and the treatment guidelines for essential hypertension. 
In the first session the learning objectives and the programme were explained 
and any questions the students asked about the Guide were answered. 
Subsequently, following the step-by-step approach of the Guide, the p-(drug) 
treatment for essential hypertension was discussed. Then, the choice of 
treatment for the four case-descriptions of essential hypertension was discussed. 
At the end of the first session the students received homework assignments for 
the second session: determine a p-(drug)treatment for pneumonia, and choose 
the treatment for the four case-descriptions of pneumonia. In the following three 
sessions the p-(drug) treatment and the treatment choice for the case-
descriptions were studied and discussed in the same way for pneumonia, 
bronchial asthma and non-insulin-dependent diabetes.  
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A clinical pharmacologist, who was instructed to facilitate the learning process 
and to stimulate the students to work out step-by-step the solutions for the 
choice and prescription of drugs, supervised each sub-group of students. He was 
instructed not to provide solutions for the patient problems. 
 
Tests  
The aim of the pre-test, post-test, and 9-month post-test (T0,T1,T2) was to 
determine the level of competence in three cognitive pharmacotherapy skills, 
i.e. choosing a (drug) treatment, determining patient information and taking 
monitoring measurements, and the level of knowledge concerning drugs. These 
skills are necessary for treating a patient with any type of core disease. 
Therefore, it had to be avoided that the tests only measured what had been 
taught during the training with regard to the four core diseases and case-
descriptions. For that reason, 21 core diseases were selected, including the four 
in the training. The selection criteria were: the diseases were, as much as 
possible, proportional to the list of 68 core diseases[9] and all diseases had been 
discussed already in the thematic blocks of the 2nd and 3rd year, so that the 
students were familiar with the pathophysiology. 21 case-descriptions were 
written, based on the 21 core diseases and on real patient’s problems, and 
carefully reviewed on content and wording by a general practitioner and a 
specialist in internal medicine from each of the two medical faculties. Two 
measurements minimised the testing effect of T0 on T1, and of T1 on T2. Each 
test consisted of seven cases. T0 included no cases with intervention diseases. In 
T1 two cases with two of the intervention diseases were randomly included, and 
T2 included two cases with the other two diseases. All other cases were 
randomly divided over the three tests. The students were not informed about the 
answers after any of the tests.  
 
The three tests (T0,T1,T2) consisted of two parts: a skills test and a knowledge 
test. The knowledge test consisted of 40 multiple-choice questions (MCQs) of the 
true-false type. The questions were derived from examinations of the thematic 
blocks in the two medical faculties. Questions were only chosen if they met the 
faculty criteria for reliability. The students had 1 hour in which to answer the 
questions. 
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In the skills test, seven written case-descriptions were presented, each with a 
different disease. The format of the cases was the same as that used during the 
training. Each case-descriptions was followed by a standard open question (SOQ) 
on: how to choose a (drug) treatment (three cases), or how to determine the 
patient information about the chosen (drug) treatment (two cases), or how to 
determine the monitoring measurements for evaluating the effect of the (drug) 
treatment (two cases). In the latter four cases, a plausible (drug) treatment was 
presented. The students had 1 hour in which to answer the questions. They could 
use their reference materials during the test, but were not allowed to use the 
training materials, or to consult each other or the supervisor. 
For the evaluation of the study-load and their opinion about their ability to solve 
pharmacotherapeutic patient problems, a questionnaire was developed for the 
3rd year students in the study group and the reference group of 5th year students. 
They were asked to mark on a 5-point scale (1: absolutely disagree – 5: 
absolutely agree) the extend to which they could solve pharmacotherapeutic 
patient problems independently with regard to the core diseases and other 
diseases, and their ability to handle patient problems systematically. They were 
also asked how much time they had spent on preparation for each session and 
their opinion about the degree of difficulty (too easy; appropriate; too difficult) 
of the pharmacotherapy training programme. 
 
Scoring and analysis 
Analysis of the answers to the knowledge test was performed electronically. 
With regard to the skills test, for each case all the different types of (drug) 
treatment or patient information or monitoring measurements were registered 
on overall scoring sheets, with a code for the identity of the students, the study 
year (3rd or 5th), the tests (T0,T1,T2), the study group and the control group. For 
each case-description an answer key was formulated and carefully reviewed by 
four experts: two general practitioners and two specialists in internal medicine 
from the two medical faculties. In addition to the specific information per case, 
general criteria were determined for the assessment of each cognitive skill. The 
answers were scored by the four experts, who were instructed to score at the 
level used for the final year learning objectives [9] and not to consult each other. 
The answers were scored on a 4-point scale (0 = no or incorrect answer, 1 = 
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disputable answer, 2 = acceptable answer, and 3 = correct answer). Scores for 
each SOQ were calculated as the mean of the scores given by the four experts. 
Unfortunately it was not possible to measure the inter or intra-rater reliability 
between the experts or to achieve consensus between the four experts about the 
score for each answer either in a consensus meeting or by means of a written 
Delphi procedure. The voluntarily participating experts felt that this would be 
too time-consuming. All differences were analysed by means of Students’ two-
tailed t-test. P<0.05 was considered to be statistically significant.  
 
Results  
A total of 85 3rd year students (95%) in the studygroup and the control group (43, 
42) participated in all three tests (T0,T1,T2) and all 5th year students (38) 
participated in T0 and T1. Only 5 3rd year students were unable to participate at 
T2 because of study reasons. There were no differences between the scores of 
students from the two different medical faculties. The results are presented in 
Figure 1 and Table 1 as a percentage of the required score for graduation, as 
previously determined in the learning objectives.  
At T0 there were no differences between the scores in the study group and the 
control group for either therapeutic cognitive skills or knowledge.  
With regard to the cognitive pharmacotherapy skills, the level of the overall 
scores in the study group increased significantly from 26.7% for the pre-test (T0) 
to 46.0% for the first post-test (T1). After nine months (T2) the level had dropped 
to 41.3%, but was still considerably higher than the score for the pre-test (T0). 
Furthermore, the scores in the study group for both post-tests (T1 and T2) were 
significantly higher than those in the control group. The increase in the overall 
scores in the study group for T1 and T2 was mainly due to two of the three 
cognitive skills: ‘choosing a treatment’ and ‘determining monitoring 
measurements’ (Table 2). The scores in the study group for these two cognitive 
skills of were also substantially higher than those in the control group. This 
difference was not found for the skill ‘determining patient information’. 
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Figure 1.  
Results of a randomised controlled pre-test/post-test intervention study. Before, directly 
after, and nine months after the training the 3rd year medical students took a test to assess 
their therapeutic knowledge and cognitive skills (T0,T1,T2). The control group just took the 
tests. The 5th year students all received the training and took the T0 and T1 test. 
Presented are the mean scores as % of the required level for graduation. 
*: significant difference compared with T0 (p<0.05) 
▪: significant difference compared with T1 (p<0.05) 
#: significant difference compared with the control group (p<0.05) 
 
 
The level of the overall scores for the cognitive skills in the 5th year reference 
group increased only slightly, but not significantly from 40.3% at T0 to 44.5% at 
T1. At T1 the level of the overall scores in the 5th year reference group did not 
differ from the scores at T1 and T2 in the 3rd year study group. 
With regard to the knowledge test, the level of the scores in the 3rd year study 
group increased significantly from 52.8% at T0 to 69.1% at T1. After nine months 
(T2) the level had decreased to 55.0%. These scores did not differ from those in 
the control group.  
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Table 1. Results of 3rd year pre-clinical students. Presented are the mean scores as % of the required level for graduation plus the 95% CI. 
The study group received the same training in cognitive therapeutic skills as the obligatory training for 5th year clinical students.  
 
 3rd year 4th year  5th year reference group 
 T0 T1 T2  T0 T1 
Study group: n = 43 43 43  38 38 
 Control group: n = 42 42 42    
Cognitive therapeutic skills   26.7 (23.9-29.6)   46.0 (43.1-48.6) # ∗   41.3 (38.8-43.8) # ∗    40.3 (36.6-44.0)   44.5 (40.6-48.4) 
   27.4 (24.4-30.4)   36.7 (33.7-39.6)    ∗   36.3 (33.8-38.7)    ∗    
choosing a (drug)treatment   33.5 (27.9-39.1)   60.2 (55.3-65.2)  # ∗   50.4 (45.1-55.7) # ∗ ▪    57.7 (51.0-64.5)   57.5 (51.5-63.5) 
   33.4 (28.2-38.6)   40.3 (35.0-45.7)     ∗  43.3 (38.1-48.4)    ∗    
determining patient information   13.8 (10.1-17.5)   30.5 (26.8-34.3)     ∗  32.0 (29.3-34.7)    ∗    22.4 (19.2-25.6)   28.5 (23.8-31.3)  ∗ 
   15.6 (12.2-19.0)   28.9 (26.0-31.8)     ∗  28.6 (25.5-31.6)    ∗    
determining monitoring measurements   36.0 (32.5-39.4)   47.8 (44.3-51.3)  # ∗   42.5 (37.8-45.2)    ∗ ▪    41.1 (36.9-45.2)   50.4 (45.1-55.7)  ∗ 
   36.2 (32.2-40.2)   42.9 (39.6-46.1)     ∗  37.4 (33.1-41.7)       ▪    
Similar cases (retention)    40.0 (36.3-43.6) #   38.8 (34.4-43.1)     37.6 (32.9-42.3) 
    29.9 (25.7-34.1)   34.0 (30.6-37.4)    
Other cases (transfer)    48.8 (44.6-52.6) #   42.5 (39.6-45.4)     45.6 (41.1-50.1) 
    39.9 (36.4-43.3)   37.6 (34.6-40.6)    
Therapeutic knowledge    52.8 (49.7-55.9)   69.1 (66.1-72.0)     ∗  55.0 (53.0-56.9)       ▪    48.8 (45.6-51.9)   68.0 (64.1-71.9)  ∗ 
 53.3 (49.7-56.9)   66.4 (63.7-69.2)     ∗ 55.7 (53.5-57.9)       ▪    
 
#: significant difference compared with control group (p< 0.05) 
∗: significant difference compared with T0 (p< 0.05) 
▪: significant difference compared with T1 (p< 0.05)
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The scores for the knowledge test in the 5th year reference group increased 
significantly from 48.8% at T0 to 68.0% at T1. The scores in the 5th year reference 
group did not differ from the scores in the 3rd year study group and control group 
for either test. For both the 3rd year study group and the 5th year reference group 
there were small differences in the score for the cases similar to those of the 
intervention diseases and those who were different.  
The questionnaire revealed that the 3rd year students were of the opinion that 
they could solve pharmacotherapeutic patient problems independently at 74% of 
the maximum possible score for the four diseases in the intervention, and at 70% 
for other diseases. For the 5th year reference group these figures were 76% and 
70%, respectively. The 3rd year students scored 74% for their ability to handle 
patient problems systematically, whereas the 5th year students scored 62%. The 
3rd year students spent two to three hours preparing for each session, while the 
5th year students spent less than two hours. All 3rd and 5th year students were of 
the opinion that the level of the training programme was appropriate. 
 
Discussion 
The aim of the study was to determine whether pre-clinical medical students are 
able to learn cognitive pharmacotherapy skills, i.e. choosing a (drug) treatment, 
determining patient information and taking monitoring measurements, 
simultaneously with gaining pharmacology knowledge. 
The level of pharmacology knowledge and the level of mastering cognitive 
pharmacotherapy skills increased significantly in all participating students. 
However, the increase in the level of therapeutic cognitive skills in the students 
who participated in the training (study group) was significantly greater than the 
increase in the control group. There was no difference between these two groups 
with regard to the level of knowledge.  
 
Generalisation, validity, reliability and feasibility 
The 85 students from two different medical faculties represented approximately 
20% of the total number and they were volunteers. Therefore, generalisation to 
the entire study year class or to students in other faculties may be questionable. 
However, the students from the VUmc did not differ from the other students in 
their year in the results of another pharmacology examination. Moreover, the 
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students were randomly allocated to the study group or the control group. Finally, 
the students from both faculties participating in this study followed a more or less 
sequential type of curriculum that was based on gaining knowledge of drugs first 
during the 4 pre-clinical years, and applying this knowledge in practice later 
during the subsequent 2 years of clinical clerkships.  
The following aspects contributed to the validity of the tests. All case-
descriptions in the skills test (SOQ) were based on different core diseases and real 
patients. The format of the cases was similar as that used in the intervention. The 
case-descriptions and questions were formulated according to a standardised 
procedure.[14]  
The following aspects contributed to the reliability. The knowledge test 
contained only questions that met the faculty criteria for reliability. With regard 
to the SOQs, for each case an answer key was formulated and carefully reviewed 
by four experts. Unfortunately, the reliability of the scores for the SOQ is 
unknown, since it was not possible to determine whether there were differences 
between the experts (inter-rater agreement) or differences in two separate 
scores by the same expert (intra-rater agreement). The four experts were 
volunteers, and therefore no time-consuming second assessment was performed. 
Furthermore, the reliability is impaired by the length of both tests. 
With regard to the feasibility, there were restrictions in both the number of 
participating students and the length of the two tests. The number of 
participating students was low because in each of the two faculties the training 
programme was supervised by one clinical pharmacologist, and therefore limited 
to two small groups with a maximum of 12 students. The length of the tests was 
restricted to a maximum of two hours since the students took the tests 
immediately after their normal training programme.  
 
Remarkable findings  
The results indicate that just acquiring knowledge, in itself, does not guarantee 
that it can be used/applied. The level of knowledge in the control group and the 
study group was the same, but the students in the control group were less able to 
apply their knowledge. Thus, applying knowledge obviously requires training 
and/or experience. Secondly, the results strongly indicate that simultaneously 
gaining and applying knowledge of drugs and acquiring pharmacotherapy skills 
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seems to be more effective than the sequential approach of gaining knowledge 
first, and then learning how to apply the knowledge. This is also supported by the 
results of the 5th year students who received a sequential training. Instead of 
learning the cognitive skills in applying the knowledge they are supposed to have, 
they seemed to use the (obligatory!) skills training for revising ‘rusty’ knowledge. 
In our previous study, in which the level of cognitive skills of medical students 
nearing graduation was assessed, we also found disappointing results for 
sequential learning with respect to pharmacotherapy.[15] The 6th year students 
who participated in this study had also followed a sequential type of curriculum, 
including the obligatory 5th year skills training. Their level of cognitive skills on 
graduation was 55.8%, which is only slightly higher than those of the 5th and 3rd 
year students in the present study immediately after their training (44.5% and 
46.0%, respectively).  
The level of cognitive pharmacotherapy skills in the pre-test (T0) in both the 
study group and the control group was approximately 27% of the required level for 
graduation. This indicates that without specific training in these skills the 
students have learned implicitly during various teaching or clinical experiences, 
such as patient demonstrations organised for diagnostic problem-solving. It is 
likely that information about the previous treatment of these patients is also 
presented and probably discussed.  
The significant increase in the level of cognitive pharmacotherapy skills between 
the pre-test and post-tests in the control group can be attributed to a well-known 
phenomenon called testing-effect. The students in the control group had learned 
from the pre-test, and therefore performed better in the post-test. [16] Because 
the study was performed in a controlled setting with a pre-test/post-test design, 
this effect was taken into consideration. 
 
Transfer-effect 
The above-mentioned considerations can be put into an even wider perspective 
when taking one remarkable finding of this study into account. The results are 
based on an assessment of cognitive skills with regard to the treatment of patient 
problems resulting from 21 diseases, including the four of the training. There was 
not only a difference between the study group and the control group with regard 
to the results with regard to the four diseases included in the training, there was 
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also a difference in the results with regard to the 17 diseases which were not 
included in the training. This implies that the students did not only remember the 
specific information they had learned during the training, but that they were also 
able to apply the acquired skills in new situations, such as solving new therapeutic 
problems. This so-called transfer-effect of therapeutic teaching has previously 
been reported in other studies.[17;18] However, it is doubtful whether a transfer-
effect is possible in diagnostic problem-solving. Psychometric analyses of tests 
showed that the performance of a student in one case is not a good predictor of 
performance in another case, because of case-specificity.[19;20] From cognitive 
psychological research it has become clear that knowledge is specific for a 
domain, e.g. for hypertension or diabetes, and therefore not transferable.[5;21] 
However, in addition to specific knowledge, doctors and students are using 
general problem-solving skills more and more when acquiring expertise.[21] 
General problem-solving skills are mainly strategies to solve problems, like sub-
dividing the problem into parts and taking decisions in the right sequence.[22] 
During the pharmacotherapy training, the students learned general problem-
solving skills by following the WHO six-step approach to pharmacotherapy, in 
which the above-mentioned strategies are used. These strategies enabled the 
students to search for specific knowledge in reference materials, instead of 
having to learn the specific knowledge. The practical consequence of this finding 
is that not all methods of treatment or all the drugs for every disease need to be 
taught and learned, provided that training in general therapeutic problem-solving 
skills is adequate. To our knowledge this is the first study to demonstrate this 
effect for pre-clinical students. 
 
Conclusions and recommendations 
Taking the above-mentioned limitations and considerations into account, it can be 
concluded that pre-clinical students seem to be able to learn pharmacotherapy 
skills simultaneously with gaining pharmacology and pharmacotherapy knowledge. 
A short training intervention on a voluntary basis already leads to a significant 
increase in the level of these skills, which lasts for at least nine months. 
Therefore, it is to be expected that implementation of an obligatory longitudinal 
training programme throughout the whole pre-clinical phase may lead to higher 
levels of cognitive skills. It is recommended that explicit practical training in 
The ability to learn cognitive skills 
63 
clinical therapeutics is continued during the clinical clerkships, including feedback 
on, and assessment of the performance of the students.  
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Abstract 
Aim: To evaluate an obligatory longitudinal context-learning programme for 
approximately 750 2nd–4th year pre-clinical students with respect to mastering cognitive 
pharmacotherapy skills, therapeutic ready-knowledge, study-load and appreciation.  
Programme: The programme consists of a weekly recapitulation lecture, a ready-
knowledge test of the ‘true minus false’ type and role-play sessions for a mix of 108 2nd-
4th year students. The role-play sessions are in the form of a consulting hour with three 
10-minute therapeutic consultations. Students alternately play the role of doctor, patient 
and peer-assessor. After having attended 15 role-play sessions (45 consultations), 4th year 
students sit for a therapeutic Objective Structured Clinical Examination (OSCE) in the 
outpatient clinic (OPC).  
Evaluation: A random selection was made of 192 2nd-4th year students, who had 
performed as a doctor during the role-play sessions, and of 49 4th year students who had 
attended the OSCE. The various treatments and information given to the patients were 
collected and assessed by clinical experts and examiners. The scores of the ready-
knowledge tests and a questionnaire were also collected.  
Results: During the role-play sessions the 2nd–4th year students mastered the cognitive 
skill ‘choosing (drug) treatments’ at 43.3%, 45.0% and 51.0% of the required level for 
graduation, respectively. For the OSCE the level was 63.9%. A reference group medical 
students nearing graduation, who had not participated in the obligatory programme, 
scored 72.6%. For the cognitive skill ‘determining the patient information’ these levels 
were 47.3%, 47.2% and 45.3% (role-play) and 69% (OSCE). The score in the reference 
group was 54.8%. For the ready-knowledge test the students scored 30.1%, 41.8% and 
44.8% of the maximum possible score, respectively. The time spent on the role-play 
sessions and self-study was approximately 1% of the total annual study-load. The 
students’ appreciation of the role-play sessions approximately 80% of the maximum 
possible score, and for the therapeutic OSCE at the OPC it was 99%.  
Conclusions: 4th year students reached levels of competence in the pharmacotherapy 
skills which were close to those of a reference group of medical students nearing 
graduation. The effects were achieved with a minimum of study-load, and a maximum of 
appreciation by the students for the context-learning methodology, the setting of which 
was as close as possible to actual practice.  
Vollebregt JA, Oldenrijk van J, Kox D, Galen van BSR, Sturm B,  Hugtenburg JG, Richir MC, Metz 
JCM, Haan de M, Vries de TPGM. Evaluation of the longitudinal context-learning programme for 
pharmacotherapy skills for pre-clinical students; a descriptive study. Submitted. 
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Introduction 
Between 1995 and 1998, an educational research project was conducted in four 
phases at the VU University medical centre Amsterdam (VUmc), the Netherlands. 
The overall aim was to evaluate the competence in pharmacotherapy of final year 
medical students, and to increase it if necessary. First, the final year learning 
objectives for pharmacotherapy knowledge, skills and attitudes were determined 
in a national survey. [1] Subsequently, also in a national survey, it was found that 
final year medical students did not meet the requirements of these objectives. [2] 
This was followed by a controlled trial indicating that pre-clinical undergraduate 
(3rd year) medical students were well able to learn how to choose and prescribe 
drugs, simultaneously with gaining knowledge of pharmacology.[3] Based on those 
results an obligatory context-learning programme for therapeutic skills was 
developed and gradually implemented in the curriculum of the VUmc for all 750 
pre-clinical 2nd-4th year medical students.  
The present paper describes a longitudinal pre-clinical context-learning 
programme for therapeutic skills and the evaluation of the programme. The aim 
was to evaluate the effect of such a programme on the level of competence of 
2nd–4th year pre-clinical students with respect to mastering cognitive 
pharmacotherapy skills, i.e. choosing a (drug)treatment and determining patient 
information (including determining monitoring measurements). The level of 
therapeutic ready-knowledge, the study-load and the appreciation of the 
programme by the students were also assessed as well as the appreciation of the 
OSCE by the examiners. 
 
Context-learning 
Context-learning is defined as learning in the context of clinical practice. This 
method of learning is mainly based on studies and theories explaining how 
medical expertise is achieved, in particular with regard to diagnostic problem-
solving. [4] By frequently solving diagnostic clinical problems, doctors gradually 
generate so-called networks of organised knowledge in their memory. More 
exposure to patients and thus increasing experience, leads to condensation of 
these networks into easy accessible diagnostic (illness) scripts. These scripts 
contain clinically relevant information about diseases, their consequences, the 
Chapter 5 
68 
context in which illnesses develop and the personal circumstances, and 
experiences of the doctor with patients. Based on recognition, the experienced 
doctors are then able to choose the right script for solving a specific diagnostic 
problem efficiently, particularly in routine cases. [5] Less is known about this 
expertise with regard to therapeutic problem-solving, i.e. choosing and 
prescribing a (drug) treatment. When having to decide on a treatment for a 
patient with a frequently recurring disease, experienced doctors confine 
themselves to the information that is already stored in their memory. [6;7] In such 
cases, doctors make a choice between two to five drug and non-drug treatments 
related to the disease or symptom(s), as a part of their personal ‘standard 
treatment guideline’. The actual choice is usually heuristic or according to “rule 
of thumb”.  
Context-learning is based on these theories, and has four basic principles [8]. The 
first is that students are learning in a setting which is the same as, or similar to 
the setting of their future profession. For medical students this will be the 
clinical (and/or research) setting. In this way, students will gain experience in 
the same way as doctors, allowing them to generate networks of organised 
knowledge in their memory [9]. The second principle is that within the relevant 
(clinical) setting students should be given the opportunity to repeat the process 
of problem-solving in different patient cases. This method of repetition allows 
the students to add new knowledge and experiences to the knowledge networks 
that will then gradually condense into easily accessible illness scripts. The third 
principle is that students should receive feedback about their performance, 
preferably immediately afterwards. With regard to clinical problem-solving this 
will contribute to the right way of generating organised knowledge and the right 
condensation into illness scripts. Finally, the students should be responsible for 
their own learning as much as possible. This means that students have the 
responsibility to ‘repair’ any lack of knowledge or skills that became apparent 
during the clinical work or the feedback. 
There are many variations in context-learning. For the medical curriculum, the 
most extreme form would consist of (daily) clinical work, in combination with 
gaining medical knowledge and training of skills, starting at the beginning of the 
medical curriculum (learning by doing). Other variations could be differences in 
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the concreteness of the setting of the future profession. These may vary from 
actual clinical practice with real patients, through practicing with standardised 
patients, solving written patient problems, and observing patient demonstrations 
or reading case descriptions in a clinical textbook.  
  
Programme 
Since September 1998, an obligatory context-learning programme for 
pharmacotherapy skills has been gradually implemented in the 2nd-4th study year 
at the VUmc for approximately 750 medical students. The programme consists of 
weekly role-play sessions for a maximum of 108 2nd–4th year students. The 
competence of nine 4th year students was assessed weekly by means of a 
therapeutic Objective Structured Clinical Examination (OSCE). The students could 
enrol for both the role-play sessions and the OSCE via a website on the Internet.  
 
Before each role-play session the essential information about symptoms, 
pathophysiology, pharmacology and treatment options of one core disease is 
discussed in a recapitulation lecture. The disease is one of the three that have 
been selected for the role-play session. The lecture is followed by an 
experimental ready-knowledge test, in which students can assess their level of 
therapeutic ready-knowledge about the three core diseases in the role-play. 
Ready knowledge is considered to be essential for treating patients correctly and 
efficiently during consultations. In one minute, 10 statements are made about the 
diseases (symptoms, pathophysiology, prognosis), the treatment (non-drug 
treatment, drug treatment, side effects, contra-indications), the basic principles 
of pharmacology and practical aspects of pharmacotherapy For each statement, 
the students have 6 seconds to indicate whether the statement is true or false, or 
that they don’t know. After the answer sheets have been collected, the right 
answers are presented and the students can calculate their own score on a copy 
of the answer sheet: each correct answer is +1, each wrong answer is -1, 'don’t 
know' answers are scored 0. This method of scoring has been chosen in order to 
prevent lucky-guess behaviour, because this could be detrimental for the patient.  
 
For the role-play sessions, 54 written case-descriptions were developed: three 
cases with a different level of complexity for each of 18 core diseases. These 
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diseases had been selected from the 68 core diseases that had been determined 
as final year learning objectives in collaboration with clinicians from the relevant 
clinical departments. [1] 
All case-descriptions were of standard design, with general patient information 
(e.g. age, gender, occupation and pregnancy), a summary of previous and current 
diseases and treatments (co-morbidity and medication), and an extensive 
description of recent history, physical examination, results of physical and 
laboratory tests and the diagnosis. For all cases the setting was general practice. 
The levels of complexity were: (A) first consultation of a middle-aged patient with 
no complicating clinical features, (B) second consultation with (in)sufficient 
effect and/or occurrence of (no) side-effects, (C) first or second consultation of a 
patient with co-morbidity and/or medication, or other complicating clinical 
features.  
 
The role-play sessions are in the form of a consultation hour with three 15- 
minutes therapeutic consultations. In a therapeutic consultation, all patient 
information is given, including the (differential) diagnosis. In order to prepare 
themselves properly, the students are informed well in advance about the three 
core diseases, but not about the cases, that have been selected for each weekly 
role-play session.  
The basic unit of the role-play sessions consists of three consultations rooms, 
three patient cases which differ with regard to the disease and the level of 
complexity (A,B,C), and nine students. Three students play the role of the doctor, 
three play the role of the patient, and three are assigned as peer-assessors. In 
each consultation room, the three case-descriptions are laid out in the desk in a 
certain order. 
Before the start of the consultations, each of the three 'doctors' is installed in one 
of the three consultation rooms. Outside each consultation room, one 'patient' is 
paired with one peer-assessor. Each patient/peer-assessor couple receives one of 
the three case-descriptions, including instructions for playing the role and a pre-
coded sheet for assessing the performance of the 'doctors'. The couples are placed 
in front of a consultation room in such a way that the order of the case-
descriptions on the desks of the 'doctors' match with that of the 'patients' and 
'peer-assessors'.  
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After 5 minutes of preparation, the couples enter the consultation rooms, and the 
'doctors' have 10 minutes to perform the task(s). The ‘doctor’ has to choose the 
(drug) treatment, together with the ‘patient’, write it down on a treatment/ 
prescription form, and give the necessary patient information. The ‘doctors’ are 
allowed to use any source of information or communication they wish. The peer-
assessors observe the consultation and score several aspects of the choice of 
treatment and the patient information on the structured assessment form on a 4-
point scale (0=insufficient, 1=moderate, 2=sufficient, 3=excellent). The couples 
then leave the consultation room, move to the next one and wait in front of it 
(couple no.1 to room 2, no.2 to room 3, and no.3 to room 1). The 'doctors' then 
have 5 minutes of preparation for the next patient and the couples can complete 
the assessment of the performance of the 'doctor' they have just visited. After 5 
minutes, the couples enter their next consultation room. This procedure is 
repeated until the 'doctors' have treated the three 'patients', and the 'patient-
assessor' couples have visited all three 'doctors'.  
Immediately after the three consultations, the ‘patients’ and peer-assessors will 
visit the 'doctors' in the same sequence again. In 3x5 minutes, they will ask the 
three 'doctors' to explain their reasons for the choice of (drug) treatment and 
record them it on the assessment form. Subsequently all nine students sit 
together and discuss the various choices of (drug) treatment and the 
performances. A clinician and a clinical pharmacologist are present as facilitators. 
Then, the ‘doctors’ collect the case-descriptions, the prescriptions and the 
assessment forms for their portfolio. Finally, all the students fill in an anonymous 
questionnaire containing questions about their current study year, the time spent 
on preparation at home for the present role-play session, their role (doctor, 
patient, assessor), and their appreciation of the context-learning programme 
including possible alternatives (see Table 1-III/IV, left hand column). 
 
After having attended 15 role-play sessions (45 consultations) during the 2nd–4th 
year, the 4th year students take a therapeutic OSCE. This OSCE is similar to the 
RPs, and consists of three basic units for assessing nine students each week. The 
main differences are that the students have to treat three standardised patients 
in the outpatient clinic (OPC), and are assessed by trained examiners. The 
students are not informed in advance about the three core diseases or about the 
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cases. The standardised patients were trained to play their role as uniformly as 
possible, and each time they played the role they were given written instructions 
in advance. On a continuous basis, each OSCE is evaluated in a structured way 
immediately afterwards with the students and examiners. A CD-ROM that can be 
found in the back cover of this thesis gives an impression of the OSCE.1 
 
The undergraduate medical curriculum at the VUmc consists of a pre-clinical 
phase of four years, followed by clinical clerkships for two years. The pre-clinical 
phase is mainly based on thematic blocks regarding certain organ systems. In each 
block students learn about anatomy, physiology, pathophysiology and clinical 
features, including pharmacology and the drugs used for the diseases of that 
system. Simultaneously, approximately 10% of the total study-load, consists of 
students learning in small groups to apply the previously gained knowledge to 
solve patient problems. The context-learning programme for pharmacotherapy 
skills is embedded in the problem-solving education  
 
Evaluation  
Population 
One year after the full implementation of the programme (2001-2002) a random 
selection was made of 192 2nd-4th year students who had enrolled as a ‘doctor’ 
during the RPs. Among them were 61 2nd year, 74 3rd year and 57 4th year 
students. 49 4th year students who took the OSCE were also randomly selected. 
This was, on average, 25% of the year classes. Non of the 'doctors', peer-assessors 
(role-play) or examiners (OSCE) were informed in advance that the evaluation 
would take place. At the end of the study year, the participating students were 
compared to the rest of the students in their year classes. There were no 
differences in peer-assessment or OSCE examiner assessment between the 
selected students and the other students. 
 
Test 
For the evaluation, six core diseases with each three case-descriptions at a 
different level of complexity (A, B, C) were selected. For each of the three study 
years, two diseases were selected that had been discussed already in the 
                                               
1 Some copies of the thesis do not contain a CD-ROM because of financial restrictions 
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thematic blocks: non-insulin-dependent diabetes mellitus (type II); iron-deficiency 
anaemia; migraine; depression; acute otitis media and osteoarthritis deformans. 
All students selected for the evaluation received a selection of these 18 case-
descriptions during the role-play/OSCE in such a way that the three cases 
concerned a differed disease and level of complexity (A, B, C).  
 
Scoring and analysis 
During the three consultations the clinical performances of the selected students 
were audio-taped, in addition to the regular observation and assessment by peer-
assessors and examiners. For each case all the different types of treatment 
recorded on the treatment/prescription forms and all the audio-taped information 
given to the patients was summarised on scoring sheets. The scorer therefore 
could not read the name of the student, the study year or whether the score 
concerned a role-play session or an OSCE. These sheets were presented to six 
independent voluntary experts, one for each disease. For each case an answer key 
was formulated and carefully reviewed by the examiners. They scored the 
different types of treatment and patient information on a 4-point scale 
(0=insufficient, 1=moderate, 2=sufficient, 3=excellent). Each student was then 
given a score for the choice of treatment and the patient information. 
Additionally, the scores for the ready-knowledge tests and the questionnaires 
were collected from all students participating in the role-play sessions. The 
questionnaire from the students and the examiners in the OSCE were also 
collected. 
All scores were entered in a database (SPSS 9.0) and descriptive statistics were 
calculated in percentages of the required level for graduation with regard to the 
cognitive skills, and as a percentage of the maximum possible score for knowledge 
and the questionnaire. All differences were analysed by applying the Student’s t-
test. P<0.05 was considered to be statistically significant. 
 
Results 
Cognitive pharmacotherapy skills 
According to the experts, the 2nd, 3rd and 4th year students mastered the cognitive 
skill ‘choosing a (drug) treatment’ at a level of 43.3%, 45.0% and 51.0% of the 
required level for graduation, respectively, during the role-play sessions (Table 1-
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Ia). The scores of the 4th year students were significantly higher those that of the 
3rd and 2nd year students. This is mainly due to their higher scores for the A-cases. 
The scores of the 3rd year students for the B-cases were significantly higher than 
those of the 2nd year students. There was no difference in scores between the 2nd, 
3rd and 4th year students for the C-cases. However, 3rd and 4th year students were 
significantly less competent in this skill in the most complex cases (C) than in the 
less complex cases (A,B). In the OSCE the score was 50.2% according to the 
experts, but the examiners, who had observed the students during the OSCE, 
scored significantly higher: 63.9%. This is mainly due to a significantly higher 
score for the C-cases given by the examiners in the OSCE. The level of the 4th year 
students in the OSCE was significantly lower than the level of 6th year students 
nearing graduation (72.6%) that had been determined in a previous study, also in 
an OSCE setting. [2] These 6th year students had not participated in the context-
learning programme in therapeutics.  
The experts indicated that the 2nd, 3rd and 4th year students mastered the 
cognitive skill ‘determining the patient information’ at 47.3%, 47.2% and 45.3% of 
the required level for graduation, respectively (Table 1-Ib). There were no 
differences between the scores of the 2nd, 3rd and 4th year students for this skill. 
For the patient cases with different levels of complexity (A, B, C) there were also 
no differences between the scores of the 2nd, 3rd and 4th year students. In the 
OSCE this level was 50.7% according to the experts. The examiners, who had 
observed the students, scored substantially higher: 69.0%. This is mainly due to a 
significant difference in the scores for the B-cases. The level of the 4th year 
students in the OSCE was significantly higher than the level of 6th year graduates: 
the summation of determining patient information (43.6%) and determining 
monitoring measurements (66.0%). [2] For both therapeutic skills the peer-
assessment scores during the role-play sessions were all significantly higher than 
the scores given by the experts (Table 1; Ia+b). 
 
Ready-knowledge of therapeutics 
The true-minus-false scores for the experimental ready-knowledge test in 
therapeutics of the 2nd, 3rd and 4th year students were 30.1%, 41.8% and 44.8% of 
the maximum score, respectively (Table 1-II). The 3rd year students scored 
significantly higher than the 2nd year students, but there was no difference 
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between the scores of the 3rd and 4th year students. There were hardly any 
differences between the scores of the students who prepared for the role of 
doctor, patient or peer-assessor. Furthermore, there were no differences 
between the scores regarding the questions about the diseases, treatments and 
basic pharmacology/ pharmacotherapy aspects. 
 
Study-load 
Students who played the role of doctor spent an average of 1½ to 1¾ hours on 
study at home in preparation for each role-play session (Table 1-III). Students who 
played the role of patient and peer-assessor spent less time on preparation. 
Together with the time spent on attending the role-play sessions (2.5 hours) the 
2nd, 3rd and 4th year students spent 22, 22 and 11.5 + 22 (OSCE) hours, 
respectively, a year for this purpose, which represents approximately 1% of the 
total study-load. 
 
Appreciation 
The students’ appreciation of the role-play sessions (RPs) was between 78% and 
82% of the maximum (Table 1-IV). The scores for possible alternatives for the RP 
showed that the students appreciated training in real practice slightly more: 77-
82% for general practice, 78-86% for the outpatient clinic (OPC). They appreciated 
problem-solving sessions in small groups and computer-assisted instruction less: 
58-70% and 48-66%, respectively. The therapeutic OSCE at the OPC was valued at 
99% of the maximum by the students. Some personal remarks made by students 
about the role-play sessions/OSCE were: ‘preparing for the RP, I used guidelines 
and I read these guidelines with the purpose of applying the knowledge in the 
RP’; I have learned that handling uncertainties is very important in the medical 
profession’; ‘RP should be used more in the other problem-oriented aspects of 
education’; ‘no change please, but an OSCE each year’; ‘RP not in the evening but 
during the day, because it is a serious subject’; ‘first RP, followed by 
recapitulation lecture and then argumentation’; ‘despite a lot of stress, it was 
very nice to take the OSCE’; ‘the setting of the OPC made you feel like a real 
doctor’; ‘this OSCE is the first time in the study that you get personal feedback 
about your performance from a real medical doctor’; ‘I would take the OSCE 
again if I could, even if there was a chance that I might fail’.
  
Table 1.  Results: the assessment of the cognitive skills (I) and knowledge test (II) as a percentage of the maximum (95% CI), 
 study-load in hours per year (III), and the questionnaire (IV) as a percentage of the maximum. 
 
 Role-play sessions OSCE Reference* 
 2nd year (n=61) 3rd year (n=74) 4th year (n=57) 4th year (n=49) 6th year (n=66) 
I. Therapeutic skills      
a. choosing a (drug) treatment      
All cases: Peer-ass. / Examiner 66.5 (62.7-70.1) 75.1 (70.9-79.2) 74.4 (70.5-78.2) 63.9 (58.1-69.8) 72.6 (71.4-73.8)@ 
 Experts 43.3 (38.5-48.1) 45.0 (40.9-49.1) 51.0 (45.2-55.2)# 50.2 (45.2-55.1)+  
      
Level A: Peer-ass. / Examiner 72.9 (66.7-79.1) 78.8 (71.8-85.9) 82.8 (75.9-89.7) 60.4 (51.5-69.3)  
 Experts 45.2 (37.4-53.0) 45.4 (38.1-52.7) 56.5 (50.0-63.1)# 55.6 (45.0-66.1)  
      
Level B: Peer-ass. / Examiner 68.0 (57.1-78.9) 75.2 (67.9-82.4) 70.8 (66.0-75.6) 59.2 (49.0-69.4)  
 Experts 46.4 (33.9-58.9) 51.7 (44.6-58.9)# 52.8 (43.4-62.3) 55.3 (49.7-60.9)  
      
Level C: Peer-ass. / Examiner 63.0 (58.3-67.7) 71.6 (66.0-77.3) 64.7 (57.9-71.3) 69.8 (61.3-78.4)  
 Experts 45.0 (38.8-51.1) 41.6 (36.8-51.1)† 44.4 (38.3-50.6) † 39.0 (30.1-47.7)+  
      
b. determining patient information      
All cases: Peer-ass. / Examiner 75.1 (70.7-79.4) 75.6 (71.1-80.1) 72.5 (68.5-76.6) 69.0 (62.2-72.2) 54.8 (53.3-56.1)@ 
 Experts 47.3 (44.5-50.1) 47.2 (43.8-50.6) 45.3 (41.6-49.0) 50.7 (47.3-54.3)+  
      
Level A: Peer-ass. / Examiner 79.0 (72.4-85.6) 75.7 (64.2-87.2) 75.8 (69.4-82.3) 62.1 (52.0-72.2)  
 Experts 46.6 (42.6-50.7) 52.4 (47.9-56.8) 45.0 (37.2-52.8) 49.2 (42.0-56.6)  
      
Level B: Peer-ass. / Examiner 73.3 (63.9-82.8) 79.3 (63.9-82.8) 74.6 (66.9-82.2) 74.6 (65.1-84.6)  
 Experts 44.4 (38.6-50.3) 45.9 (42.6-49.4) 40.8 (34.0-47.7) 49.2 (39.9-52.5)+  
      
Level C: Peer-ass. / Examiner 71.2 (64.7-77.7) 73.2 (67.7-78.7) 59.8 (53.5-66.0) 63.2 (53.3-73.0)  
 Experts 54.7 (49.8-59.6) 51.2 (45.5-56.9) 50.0 (45.4-54.7) 54.5 (47.7-61.3)  
 
 
  
 
II. Ready-knowledge (% of max.) 2
nd year (n=61) 3rd year (n=74) 4th year (n=57) 4th year (n=49)  
Students with doctor-role 36.4 (29.6-43.2) 44.7 (39.6-49.8) 44.0 (35.3-52.8)   
Students with patient-role 27.6 (21.9-33.2) 38.0 (31.6-44.4) 41.8 (33.1-50.6)   
Students as peer-assessor 25.6 (18.8-32.5) 42.3 (37.6-46.9)# 48.5 (39.3-57.7)   
Average score 30.1 (26.4-33.9) 41.8 (38.7-44.9)# 44.8 (39.6-49.9)   
      
III. Study load (hours)      
Preparation for doctor-role 3½ 3 1¾ 22  
Preparation for patient-role 1½ 1½ 1   
Preparation for peer-assessor 2 2½ 1¼   
Role-play attendance 6 sessions 15 15 7½   
Total hours per year 22 22 11.5   
      
IV. Appreciation (% of max.)      
Current programme:  role-play 78 82 78   
  OSCE    99  
Alternatives : real practice GP 82 77 80   
 real practice OPC 78 86 83   
 small group teaching 58 67 70   
 computer education 61 66 48   
 
# : difference between the scores of 4th and 3rd year students, or 3rd and 2nd year students 
†: difference between the scores for level C cases and those for level A and B cases 
+: difference between clinical experts and clinical examiners 
@: significant difference with OSCE (4th year) 
* [2] 
GP: general practice 
OPC: outpatient clinic 
OSCE: objective structured clinical examination 
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Some comments made by the examiners were: ‘each successive year, the level of 
performance of the students had improved’; ‘the examination is time-consuming 
and the doctors from the department have to come for a whole year, but it is very 
nice to be involved’; ‘5 minutes is not long enough for the ‘doctor’ to give his or 
her reasons for the choice of (drug) treatment, and as an examiner you want to 
teach the student something’.  
 
Discussion 
The aim of the study was to evaluate an obligatory context-learning programme 
for pharmacotherapy skills. It was organised as part of the existing pre-clinical 
curriculum that mainly consists of thematic blocks and patient-oriented problem-
solving in small groups. The primary aim of the study was to evaluate the effect 
of context-learning on the level of mastering cognitive pharmacotherapy skills in 
2nd, 3rd and 4th year pre-clinical medical students. A secondary aim was to 
evaluate the programme with regard to the level of ready-knowledge, the study-
load, and the appreciation of the students as well as the teachers. 
The five main findings of this study are that:  
1. there was a relatively small increase in the level of mastering cognitive 
pharmacotherapy skills for 18 core diseases by 2nd-4th year medical students, 
with a significant increase in the 4th year students;  
2. the level of ready-knowledge of pharmacology and pharmacotherapy increased 
significantly, in particular in the 3rd year;  
3. the pre-clinical students reached both levels after only 15 role-play sessions 
(five times playing the role of ‘doctor’) with a relative low study load;  
4. the students highly appreciated context-learning, in particular the OSCE at the 
OPC, as did the examiners, although for them it was time consuming;  
5. the level of the 4th year students was close to that of 6th year graduates who 
had finished their clinical clerkships but had not followed the pre-clinical 
context-learning programme.[2]  
 
Generalisation, validity, reliability and feasibility 
The students were randomly selected from the three year-classes and from the 
students who participated in the OSCE. The selected students did not differ from 
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the rest of the students in their year-class with respect to the peer-assessment 
and the OSCE assessment. Therefore, the results can be generalised to all VUmc 
students in the 2nd–4th year of the, but to a lesser extent to students in other 
medical faculties because of differences in the curricula of the various medical 
faculties in the Netherlands.  
The following aspects contributed to the validity. The role-play sessions and the 
therapeutic OSCE took place in a similar setting, and the same structured 
assessment form was used. Furthermore, the case-descriptions were based on real 
patients in a general practice setting, and were all standard in design. Therefore, 
the content validity was high. 
With regard to the OSCE, the following aspects contributed to reliability. In 
general, the standardised patients were instructed by role-training and 
instructions. However, it is not clear to what extent they consistently played the 
same role. For each case an answer key was formulated and carefully reviewed by 
the examiners. All examiners were instructed on how to use the structured 
scoring list and each week nine examiners participated in the OSCE. It was not 
possible for the clinical departments to send more examiners in order to 
determine whether there were differences between examiners. Unfortunately the 
reliability of the scores for the OSCE remains unknown. For similar reasons, it was 
not possible to test the inter-rater reliability with respect to the expert scoring of 
both the role-play sessions and the OSCE.  
The absolute figures for the levels of mastering the cognitive pharmacotherapy 
skills in the OSCE should be interpreted with some care, in particular the 
differences between the (higher) scores given by the examiners and the (lower) 
ones given by the experts. Differences in the method of assessment seem to play 
an important role. In contrast to the experts, the examiners knew that they were 
assessing 4th year students, observed the students, and thus knew the content of 
the conversation and discussion with the patient. They also discussed the 
treatment choice with the student during the 5 minutes immediately following 
the consultation. The reasons given by the students for their choice rightfully 
influenced the score given by the examiners, whereas the experts did not know 
the students’ reasons. In particular, this might have contributed to the 
differences in the choice of treatment in the C-level cases and the patient 
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information in the B-level cases. These cases were complex, and the standard 
treatment or communication was not always applicable. It can be argued that 
reasons given by the students in these cases might influence the examiners to a 
greater extent than in the A-level cases. On the other hand, because of this 
difference in assessment, it can be argued that the experts scored more 
objectively, whereas the examiners may have been influenced by the 
circumstances. For example, the assessment of a stressed student struggling to 
survive may be different if it is preceded by a consultation in which the student’s 
performance was very professional. However, each student was assessed by three 
different examiners and in most cases the scores and opinions of the examiners 
did not differ very much.  
With regard to the feasibility of the role-play sessions, 15 sessions was the 
maximum for both logistic and time-consuming reasons, since there was very little 
time left in the fully occupied curriculum. Financial reasons and lack of time for 
the examiners restricted the OSCE to three stations. 
 
Other findings of the programme  
The scores for the experimental ready-knowledge test may seem low. However, 
an average true-minus(!)-false score of 44.8% may be considered relatively high 
because the correction for guessing is normally made later for the entire test 
without the deduction of false answers. Furthermore, it is a rather stressful type 
of examination to which the students were not yet fully accustomed to it. In fact, 
at first they objected strongly because they had too little time to reflect on each 
short statement (6 seconds), and because they were ‘punished’ for guessing. After 
the importance of having correct ready knowledge in daily practice was 
repeatedly explained and the students experienced the need or ready-knowledge 
in the role-play sessions, their resistance decreased.  
Because the context-learning programme is only a small element in the whole 
curriculum, the measured impact cannot be ascribed to this programme solely. 
However, training in therapeutic problem-solving is scarce in education in the 2nd-
4th study years. The emphasis of the problem-oriented education is mainly on 
diagnostic problem-solving. The higher levels of competence in the skills in 
comparison with earlier measurements in the control-group of pre-clinical 4th year 
students, indicate that the measured impact is due to the new programme.[3] It 
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has been reported in pre-clinical students the transfer of general problem-solving 
skills in pharmacotherapy might be a contributing factor. General problem-solving 
skills are mainly strategies such as subdividing the problem in parts and taking 
decisions in the right sequence. Using these strategies, the students were able to 
search for specific knowledge in reference materials.[3]Therefore it can be 
expected that they are able to employ the skills in all 68 core diseases 
determined in the final year learning objectives, even though they only learned 
the pharmacotherapy skills for 18 core diseases in the context-learning 
programme.  
 
Learning conditions 
In addition to the above described methodological aspects, in the interpretation 
the results of this study one should take into account the learning conditions of 
the context-learning programme. These conditions are, in particular, determined 
by its four basic principles: the setting, the number of repetitions, the feedback 
and the personal responsibility for learning.  
The setting, i.e. role-play sessions can be placed in about the middle of the 
spectrum of concrete settings of the future profession. This spectrum runs from 
real practice with real patients (under supervision), via simulated practice 
situations with standardised patients and role-play, to less concrete situations 
such as solving written patient problems in small study groups, patient 
demonstrations during lectures, and reading case descriptions in textbooks. [8] 
Role-play was the maximum possible achievement, because it is difficult to obtain 
real practice settings and (standardised) patients for large numbers of students. It 
can be argued, however, that role-play sessions in which students play the roles 
of doctor, patient and peer-assessor have certain advantages. For instance, 
students indicated that both the role of patient and the assessor gave them the 
opportunity to observe and discuss the performance of three doctors for the same 
case and consultation. Although all the students favoured the role of doctor, and 
said that it was very instructive, they were of the opinion that they also learned a 
lot from the other roles.  
It is not known what the ideal number of repetitions is in order to add knowledge 
and experience to the knowledge networks and to condense these into easily 
accessible illness scripts. For about 750 students from three year-classes, 15 role-
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play sessions and a therapeutic OSCE for each student was the maximum possible 
for reasons of logistic (consultation rooms), personnel and teaching time. The 
results of this study are based on the fact that the student only played the role of 
the doctor five times, and observed either as a patient or as an assessor the 
performance of their peer-students 10 times. This means that each student solved 
only 15 patient cases and observed another 30 cases, and spent about 22 hours 
per year on the programme. Nevertheless, the examiners were of the opinion that 
the level of the cognitive pharmacotherapy skills was sufficient for students to 
commence their clinical clerkships.  
The third principle concerns the quality of feedback the students received on 
their performance. Ideally, feedback is given immediately after performance, by 
teachers who are trained in giving feedback.[10] The feedback in this programme 
was performed by peers after the role-play sessions. The results show that the 
assessment by peers did not meet the expectations. For all three study years, and 
for all levels of cases, the peer assessors scored much higher than the experts, 
and even higher than the OSCE examiners in the 4th year. There are several 
possible explanations. First, as the results of the study-load indicated, the peer-
assessors spent less time on preparation than the students who played the role of 
the doctor. Secondly, the peer-assessors lacked clinical experience. Thirdly, 2nd 
year students sometimes assessed 3rd or 4th year students. The fourth reason is 
that students, when asked about the reason for their high assessment scores, 
indicated that it was 'not done' to criticise fellow-students who are also friends or 
at least fellow-students facing the same problems. Finally, the students were not 
trained to assess the skills during role-play sessions. The above-mentioned reasons 
explain why the peer-assessors were not able and/or not willing to assess their 
fellow-students more critically.  
The final principle for efficient context-learning is the students’ responsibility for 
their own learning. Ideally, the students should have ‘repaired’ any lack of 
knowledge and skills that became apparent during the role-play sessions and the 
feedback. The present study has not examined this effect, though the relatively 
low study-load indicates that this was not optimal. This is due to the fact that the 
pharmacotherapy programme had to compete with other elements in the teaching 
programme. Other obligations, and in particular examinations, often had a higher 
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priority. The fact that at least part of the other elements of the teaching 
programme is merely learning factual knowledge, accounts for the students being 
less responsible for their own learning, but contributes to ‘spoon-feeding’ 
behaviour. They had to become accustomed to their own responsibility and to 
shift from this behaviour (‘tell me what I should do/learn, and I will do it, take 
the exam and get it over with’) to self-reflection and self-learning.  
 
Conclusions and recommendations 
Taking the above-mentioned limitations and considerations into account, we 
found a strong indication that pre-clinical context-learning has a positive effect 
on learning cognitive pharmacotherapy skills, i.e. choosing a drug treatment and 
determining patient information. This effect has been obtained with a sub-
optimal form of context-learning (role-play sessions in the medical faculty and an 
OSCE in the outpatient clinic), and a minimum of study-load, and is highly 
appreciated by students and examiners. Recommendations for further education 
and research are based on the four principles of context-learning. With regard to 
the context of the programme, it is recommended that the students are able to 
learn in an environment with the highest level of concreteness.[8] This means that 
the students gain personal experience in seeing and dealing with real patients in 
the clinic. In order to create a maximal realistic situation, students should be 
confronted with the entire consultation so that they can apply both their 
diagnostic and their therapeutic skills.[11] The effect of such a programme on both 
the level of knowledge and the clinical skills of future doctors should be studied 
on a continuous basis.  
With regard to the context-learning programme for pharmacotherapy described 
here, it is recommended that the optimum of number of sessions is to be 
determined. Therefore, both the level of pharmacotherapeutic skills and 
knowledge of the students should be measured on a continuous basis including 
during the two years of clinical clerkships, with at least a therapeutic OSCE in 
each study-year. The peer-assessment can be improved by taking measures to 
ensure that the students prepare themselves better, for instance by introducing 
an obligatory knowledge-test as an entry-test for each session, to give students 
the opportunity to gain clinical experience, and to train them in peer-
assessment.[12] Finally, to improve the students’ responsibility for their own 
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learning, it is recommended to replace the student with the role of patient and 
the peer-assessor randomly by a standardised patient and an examiner. It is to be 
expected that after these improvements, and after carefully evaluation of their 
effects, future doctors will be better prepared for the rational prescriptions of 
drugs.  
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This thesis describes four phases in the development of an undergraduate 
curriculum for pharmacotherapy. In the Introduction, the reason for this 
development has been discussed (Chapter 1). It was generally believed that 
improvement in the undergraduate pharmacotherapy teaching-programme was 
called for, and would contribute to better drug-prescription by doctors. 
Therefore, a project was initiated with the general aim to evaluate the level of 
competence in pharmacotherapy of medical students nearing graduation, and to 
seek ways to improve it if necessary. Four studies were performed between 1995 
and 2002 in an attempt to achieve these aims. The results of these studies 
indicated that:  
1. The Dutch final year pharmacotherapy objectives, determined in a national 
survey in 1995, require that final year medical students should be able to treat 
patients with a core disease, and for that purpose they should be competent in 
all relevant pharmacotherapy skills at the highest possible level, have 
sufficient knowledge of pharmacology, and have a critical attitude with regard 
to irrational drug-prescribing (Chapter 2).  
2. In 1996, a randomly selected group, consisting of 5% of the final year medical 
students in the Netherlands, did not sufficiently comply with the requirements 
for these objectives, in particular with regard to the necessary cognitive, 
communication and motor skills (Chapter 3).  
3. In 1997, in a controlled research setting, 3rd year medical students from the 
VUmc and AMC/UvA showed their ability to learn cognitive pharmacotherapy 
skills simultaneously with gaining pharmacology knowledge when participating 
in a short problem-solving training programme for pharmacotherapy (Chapter 
4). 
4. There was an increase in the level of competence in cognitive 
pharmacotherapy skills and pharmacotherapy knowledge in 2nd-4th year VUmc 
students who participated in an obligatory context-learning programme for 
pharmacotherapy between 1998 and 2002 (Chapter 5). 
 
The specific methodological aspects of these studies, in particular with respect to 
the generalisation of the results, and the validity and reliability of the tests, have 
been discussed in the various chapters. They will be discussed here more 
generally within the context of competence and context-learning. 
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Competence and context-learning  
The main two themes of this thesis are the competence of medical students with 
regard to pharmacotherapy (cognitive) skills, and the context in which these skills 
are learned and assessed. Both have been presented and discussed in the various 
chapters. In particular the objective of the controlled study was to determine 
whether pre-clinical students were able to acquire these skills (Chapter 4), and in 
the following study a context-learning programme for pharmacotherapy skills was 
evaluated (Chapter 5). The main findings of these two studies will be discussed in 
general with respect to current considerations regarding clinical competence and 
performance and the concept of context-learning. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1  ‘Pyramid’ by Miller as an illustrative framework for discussing the assessment of 
clinical skills, competence and performance [1] 
 
Competence 
For illustrative purposes, Miller presented a framework in 1990 when discussing 
various forms of assessment, and in particular the assessment of clinical skills, 
competence and performance.[1] He presented this framework in the form of a 
pyramid (Figure 6.1). At the base it indicates that a student, a resident, or a 
physician should have knowledge in order to carry out the required professional 
functions effectively. The next layer of the pyramid indicates that students must 
also know how to use this knowledge for the required functions. For example the 
skill that is needed to acquire information from a variety of human and laboratory 
sources, to analyse and interpret the data, and finally to translate such findings 
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into a rational diagnostic or management plan. Miller quotes Webster’s dictionary 
(without reference) that defined this ‘know-how’ quality as competence.1 The 
subsequent layer indicates that students should be able to demonstrate (in an 
observed or examination setting) not only that they know and know how, but that 
they can also show how they do it when faced with a patient. Miller calls this 
ability performance.1 Finally, in the top layer, he raises the important question of 
whether what is performed in an artificial learning or examination setting can 
accurately predict what a graduate actually does when functioning independently 
in clinical practice, the action component of professional behaviour.1 
Furthermore, Miller states, on the one hand, that it may be reasonable to assume 
that either action or performance implies achievement of the more basic 
elements of the triangle. On the other hand, measurement of knowledge and 
competence cannot be assumed to predict fully and with confidence the 
achievement of the more complex goals. He concludes in this respect that 
faculties should seek both instructional methods and evaluation procedures that 
fall in the upper reaches of this pyramid, since examinations drive the 
educational system. Examinations convey in the most clear and realistic terms 
what students must learn or do in order to succeed.  
 
The reason for, and the overall aim of this thesis are in concordance with the 
above-mentioned theory. On the basis of the literature presented in the 
Introduction, it has been concluded that the rationality of drug-prescribing found 
in postgraduates (and practising doctors) was insufficient. Since these young 
doctors had graduated after passing clinical examinations (performance), it can 
also be concluded that the drug-prescribing performance of students in an 
examination setting did not accurately predict what they actually would do when 
functioning independently as postgraduates in a clinical practice (action).  
Furthermore, there are indications that drug-prescribing skills may not even be 
addressed in clinical examinations. Therefore, the overall aim of the studies 
described in this thesis was to seek instructional methods and evaluation 
procedures relevant to pharmacotherapy training. 
 
1 In this thesis the definitions of competence and performance are those formulated by 
Rethans: competence is defined as what a person is capable of doing in an 
observed/examination setting, and performance is what a person does in daily practice.[17] 
Miller defines the first (competence) as performance and the second (performance) as action. 
General discussion 
91 
Context-learning  
In the third study (Chapter 4) it was shown that pre-clinical students are able to 
learn cognitive pharmacotherapy skills, i.e. choosing and prescribing drugs, 
simultaneously with gaining knowledge. According to Miller, competence in 
choosing and prescribing drugs was trained. Furthermore, it has been discussed 
that this outcome was in concordance with the theories concerning context-
learning and gaining expertise. There is growing evidence that gaining knowledge 
along with applying knowledge is more effective than sequential learning.[2] This 
is explained by the increase in experience of the doctor. Frequently solving 
(diagnostic) problems and more confrontation with patients in the context under 
which illnesses develop, enables the doctor to choose the right script for solving a 
specific (diagnostic) problem efficiently.[3-5] For that reason, the main 
instructional and evaluation (assessment) method used in the pharmacotherapy 
programme described in Chapter 5 was a context-learning setting: role-play 
sessions and an examination (OSCE) at the outpatient clinic. In this way the 
students gained the pharmacology and pharmacotherapy knowledge 
simultaneously with solving patient problems, and stored this knowledge together 
with the clinical problems for which it was used. The assumption is that when the 
student has to solve such patient problems again, for example in clinical practice 
or in a clinical examination, the knowledge will be recalled much more accurately 
and rapidly.[6]  
 
As discussed in Chapter 5, context learning may vary with regard to the 
concreteness of the setting of the future profession. The most realistic concrete 
form is actual clinical practice with real patients. Less concrete forms are 
practising with standardised patients, solving written patient problems, observing 
patient demonstrations and reading case descriptions in a clinical textbook, the 
latter being one of the least realistic forms.  
Similar to Miller’s pyramid concept, the most realistic form of context-learning –
learning by doing in actual (clinical) practice- can be illustrated in a reverse 
pyramid (Figure 6.2). Under supervision, students are placed in an actual 
practice situation from the start of their studies. At first, the tasks are relatively 
simple, but with a certain level of responsibilities. Gradually, as the student 
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gains more experienced, the level of performance and competence will grow, 
together with the responsibilities, and the knowledge will increase.  
For various reasons, this extreme form of context-learning will not be suitable for 
medical education. Because medical problems are too serious and often require 
correct and immediate intervention, patients cannot be put into the hands of an 
unskilled student, even under supervision. Moreover, this method is probably 
highly inefficient and with such an approach it would take a lot of time for 
students to achieve the required level of professionalism. Furthermore, the large 
body of knowledge that is available, can be studied in a relatively short time. 
Moreover considerable experience has been gained in training clinical 
competence. Another reason why it is unsuitable, is that first year medical 
students do not know the scope of the clinical problems they will encounter as 
physicians. They are therefore less able to determine the extent to which the 
skills and knowledge they have to learn will be useful.[7] On the other hand, when 
students are confronted with clinical problems that they have to solve by 
themselves, they become aware of their own deficiencies, and are better able to 
tailor the learning to their own needs.[8] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 Combination of competence and context-learning 
 
 
Miller’s pyramid of and its interpretation can also be applied to sequential 
learning, i.e. learning knowledge first, followed by learning how to apply this 
knowledge in problem-solving (competence, performance and action). In the 
extreme form of context-learning this is the other way around: through training in 
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actual practice (action) the level of performance, competence and knowledge will 
gradually grow. A combination of both would probably result in an acceptable and 
efficient curriculum. This can be illustrated by combining both of these pyramids 
(Figure 6.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 Combination of Miller’s pyramid and the reversed one 
 
For example, from the start of their study medical students could spend half a 
day in a clinical practice and half a day in a (clinical) research setting each week. 
The rest of the week consist of lectures, teaching in problem-solving in small 
groups, laboratory and skills training, self-study, and working out assignments 
derived from the patients they have seen that week and from the research 
activities during that week. Each year the students will be given more 
responsibilities, depending on their performance and examination results. 
Another example is the curriculum that is currently being developed at the VU 
University Medical Centre (Van Rossum H; www.med.vu.nl). Its framework is  
presented in Figure 6.4. and shows similarity with the two combined pyramids.  
In addition to working in actual practice, students are simultaneously studying 
(knowledge) and practising (skills). Starting from the first year, the work in actual 
practice gradually increases, but at the end of the curriculum the amount of time 
allocated to studying and practising is still considerable. 
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Figure 6.4 Model of medical curriculum of VU university Medical Center 
 
In general, learning involves building networks of information and experience. 
Learning is goal-oriented, which means that the relationships between the various 
facts (knowledge) and actions (competence/performance/experience) are 
specified. The way new knowledge will be stored in the memory, and the amount 
of new knowledge that can be stored, depends on the meaning that can be given 
to it, i.e. the extent to which it can be linked to networks of prior knowledge and 
experiences.[9] Therefore, learning new information depends on the extent of 
activation of prior knowledge, and both new and old knowledge can be 
restructured in elaborated causal networks.[10] This implies that context-learning 
should be part of a medical curriculum from the beginning, together with gaining 
knowledge and the skills to use this knowledge for medical problem-solving.  
 
The evaluation of such a context-learning programme – in fact of any teaching 
programme - should be aimed at measuring the knowledge, competence and, 
eventually, the performance of graduates in such a way that it can predict fully 
and with confidence their future achievements in daily practice. The method of 
evaluation presented in the last study (Chapter 5), based on a therapeutic 
examination (OSCE) in the outpatient clinic with standardised patients and 
clinicians as examiners, is just a first step in that direction. Important issues with 
regard to the reliability of this measurement still have to be addressed: e.g. 
inter-rater agreement, inconsistency of standardized patient performance, the 
required number of stations due to variation in student performance across the 
stations, and the required number of examiners.  
 
 
 
study years 
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Equally important is the issue of the validity of the measurements. Apart from the 
relatively rare empirical validation studies (for example, measuring concurrent 
validity by means of correlation studies) two other issues are of importance in this 
matter.[1] The first is the widely accepted fact that performance is embedded in 
knowledge that can be expected to increase, and thus will influence performance 
as the stage of education advances. The second is that the results of correlation 
studies are usually derived from the scores of rankings of norm-referenced tests, 
rather than from the specific behavioural achievements of mastery-referenced 
appraisals. However, there is still debate about the most effective methods for 
developing performance standards. According to Miller this issue has been 
successfully evaded in the past through the application of norm-referenced 
testing, simply ranking candidates with arbitrary cut-off points. This would reflect 
distinctions far more than differences. For ‘high risk examinations’ that qualify 
candidates for independent general or specialist practice, it seems imperative to 
adopt a criterion-referenced method. However, combining an increase in both 
reliability and validity of the tests for measuring performance will be difficult, 
given the reverse relationship between the two.  
 
General recommendations 
Based on the results presented in this thesis, and on the above-mentioned 
considerations regarding clinical competence/performance, the following general 
recommendations are made for future medical education and research on medical 
education. 
  
Medical education 
It is recommended that when universities are planning to change their 
pharmacology/pharmacotherapy curriculum, the learning objectives for 
pharmacotherapy are first determine in a similar way as that is described in this 
thesis, and that the level of competence of the graduates is measured. If this 
level is not satisfactory, sub-levels for these learning objectives should be 
determined for the relevant years or elements of the undergraduate curriculum.  
 
According to the findings described in this thesis, a teaching and assessment 
programme should be chosen that is as close to context-learning and assessment 
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as possible. Detailed information about these subjects, and also about 
pharmacotherapy teaching, can be found in the Teacher’s Guide to Good 
Prescribing. [11] In addition to providing valuable information about various 
teaching and assessment methods, it also gives advice on how to mobilise support 
for changing the pharmacotherapy curriculum and how to perform research in this 
field. 
 
During and following the implementation of changes in the curriculum the 
competence/performance of students should be assessed according to the levels 
required to meet the final year learning objectives. In order to stimulate the 
students to learn in the best possible way, they should be informed and instructed 
at the start of the learning programme about the methods of teaching and 
assessment. [12;13] 
 
Research 
Most studies of cognitive processes in medical education are focussed on 
(experienced) doctors who have already graduated.[14-16] For undergraduate 
teaching and learning it is also important to know how medical students can build 
up their expertise in pharmacotherapy skills together with gaining knowledge. 
Therefore, the way undergraduates learn how to choose and prescribe drugs, for 
example by think-aloud protocols could be studied. This could be done by 
comparing students following different types of curricula with those following 
curricula including context-learning in the training programme.  
 
The studies described in this thesis, were mainly restricted to pre-clinical 
students. In particular, the effect of pre-clinical context-learning on the level of 
mastering pharmacotherapy knowledge and skills of graduates is not known. 
Therefore, it is recommended that the influence of pre-clinical context-learning 
in pharmacotherapy skills on actual performance should be studied during the 
clinical clerkships, and later in daily practice. To optimise the method of testing, 
further research on the validity and reliability of the tests is needed in order to 
be able to predict future behaviour in actual practice.  
This latter is not an easy task because after graduation many other factors may 
influence drug-prescribing behaviour. Nevertheless, such studies should be 
General discussion 
97 
performed, since medical faculties have an obligation to society to provide 
graduates who are able to choose and prescribe drugs in a rational way.  
 
This study contributed data to increase the available knowledge about medical 
education, in particular with respect to the context-learning and assessment of 
pharmacotherapy cognitive and communication skills. However,  
‘it will not be easy to convince conservative medical faculties, 
reasonably comfortable with the current conventions that allow 
clinical impressions to substitute for systematic accumulation of 
behavioural evidence, that change is in order. Neither will it be 
possible to convince them with data alone. But without data 
passionate arguments are bound to falter for, as one keen observer 
pointed out many years ago, where data are sparse opinions are 
plentiful. And that would seem to describe the status of clinical 
skills/competence/performance assessment in many parts of the 
globe’.[1] 
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This thesis deals with the analysis and amelioration of the pharmacotherapy 
training for undergraduate medical students. The general aim was to evaluate the 
level of competence in pharmacotherapy of medical students nearing graduation, 
and to seek ways to improve it if necessary. Competence in pharmacotherapy is 
defined as what the student is capable of doing in the field of pharmacotherapy, 
and consists of pharmacotherapy knowledge, skills and attitudes. For this 
purpose, four studies were designed and conducted. The main results and 
conclusions are summarised below. 
 
In the Introduction it has been stated that preventable errors are being made in 
drug-prescribing and that irrational prescribing still occurs. Improvement in the 
drug-prescribing behaviour of medical doctors is not easy to achieve, because 
many factors influence this behaviour. It is possible that medical doctors have not 
been adequately trained in rational drug-prescribing and, therefore they cannot 
address optimally the factors that result in irrational prescription. 
 
Before the level of competence in pharmacotherapy of final year students could 
be assessed, the learning objectives for pharmacotherapy (requirements the 
student has to meet) had to be determined. This was the aim of the first study, 
which is performed in 1995 and described in Chapter 2: Learning objectives. A 
survey was performed among the responsible heads of relevant clinical 
departments of all eight medical faculties in the Netherlands. First, by means of a 
literature survey, all known specific and general learning objectives were 
identified. Specific learning objectives describe the diseases and symptoms, the 
treatment of which should be mastered by final year students. General learning 
objectives describe the knowledge, skills and attitudes that are necessary to be 
able to treat these diseases and symptoms. For each disease the respondents 
were individually asked to indicate the required level of mastery needed for 
graduation with regard to the treatment, including the relevance of the necessary 
knowledge, skills and attitudes. To reach maximum consensus between the 
respondents, a so-called Delphi procedure was used. During this procedure the 
participants are repeatedly confronted with each other’s opinion via a structured 
survey. In medical education and in clinical practice the Delphi procedure is an 
approved method to achieve consensus about a certain issue. 
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The study shows that for graduation, medical students should be able to master 
the treatment of 68 (out of 135) diseases and symptoms at the highest level 
(professional level): ability to choose the correct (drug)treatment and prescribe 
drugs independently for any patient. For 37 diseases the required level is the 
ability to choose the (drug) treatment, and for 9 diseases it is sufficient to have 
knowledge about the drugs which are relevant for the treatment. For the 
remaining 21 diseases no consensus was reached as to the level of mastery. 
For the treatment of these 68 core diseases, medical students should master all 
relevant cognitive, communication and motor skills at the highest level, have 
sufficient knowledge of the basic principles of pharmacology and clinical 
pharmacology, and have a critical attitude towards disturbing influences which 
might cause irrational drug-prescribing. 
 
After the learning objectives had been determined, the following study 
investigated whether final year medical students in the Netherlands met the 
requirements defined in the final year learning objectives for pharmacotherapy, 
i.e. the cognitive, communication and motor skills needed to treat the core 
diseases. This study is described in Chapter 3: Competence in pharmacotherapy. 
76 6th year students from all Dutch medical faculties took two tests: a Short Essay 
test (SE) and an Objective Structured Clinical Examination (OSCE) in a simulated 
practice setting with standardised patients. In the SE, which was focused on 27 
patient problems, three cognitive pharmacotherapy skills were tested: (1) 
choosing the (drug) treatment; (2) determining the patient information, and (3) 
determining the monitoring measurements. In the OSCE, which consisted of eight 
consultations concerning eight patient problems, not only the three cognitive 
skills were tested but also the communication and motor skills. During the OSCE, 
the students’ performances were observed and the communication and motor 
skills were scored immediately. In both tests the cognitive skills were 
subsequently scored on a 4-point scale by independent experts in three medical 
disciplines from three universities: internal medicine, general practice and 
clinical pharmacology. 
For the SE and the OSCE the mean scores for mastering the cognitive 
pharmacotherapy skills were 55.8% and 60.7%, respectively, of the required level 
for final year medical students. The score for communication and motor skills at 
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the OSCE test was 73.0% and 53.6%, respectively. Therapeutic errors, i.e. a score 
of 0 or 1 on the 4-point scale, varied from 18.6% to 84.1% for the performances of 
all cognitive, communication and motor skills during both tests. 
The results of this study strengthen the opinion that in 1996 the competence of 
medical students nearing graduation did not meet the requirements for 
pharmacotherapy skills as defined in the final year learning objectives.  
 
The main method of teaching is still often focused on learning knowledge first, 
followed by applying this knowledge in patient problems. In the following study, 
described in Chapter 4: Ability to learn cognitive skills, the aim was to 
determine whether 3rd year medical students could learn cognitive 
pharmacotherapy skills, i.e.: (1) choose the (drug) treatment; (2) determine the 
patient information, and (3) determine the monitoring measurements, 
simultaneously with obtaining the necessary knowledge of pharmacology. 
In 1997, a controlled trial with a 9-month follow-up was conducted, in which a 
control group (42 students) followed the usual learning programme and a study 
group (43 students) followed an experimental programme in addition to the usual 
programme. The 85 students were randomly assigned to the study group and the 
control group. The experimental programme consisted of training in 
pharmacotherapy skills during four weekly group sessions combined with self-
study. The programme was identical to the obligatory pharmacotherapy skills 
training for 5th year students who were about to enter their clinical clerkships. 
Before, immediately after, and again nine months after the training the 3rd year 
students were tested. The tests consisted of a knowledge test and a cognitive 
skills test. As a reference 38 5th year students took the same tests. 
The study showed that before the training there was no difference in the level of 
the cognitive skills between the 3rd year study group and the control group: 26.7% 
and 27.4% of the required level for graduation, respectively. Immediately after 
the training the level of competence in the study group had increased (46.0%), 
and showed no significant decline nine months after the training (41.3%). The 
control group scored significantly lower on both post-tests: 36.7% and 36.3% 
respectively. There were no differences between the study group and control 
group with regard to the level of knowledge of pharmacology and 
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pharmacotherapy before (52.8/53.3% of the maximum), immediately after 
(69.1/66.4%) and nine months after the training (55.0/55.7%). 
The level of cognitive skills of the 5th year students before and immediately after 
their obligatory training was more or less the same: 40.3% and 44.5% of the 
maximum; whereas their level of knowledge increased significantly from 48.8% to 
68.0% of the maximum. 
The conclusion was that 3rd year medical students were able to learn the 
pharmacotherapy cognitive skills simultaneously with gaining pharmacology and 
pharmacotherapy knowledge. The level of knowledge and skills of the 3rd year 
students after the training was similar to the level of the 5th year students. These 
students mainly ‘brushed up’ their ‘rusty’ knowledge. They were hardly able to 
acquire cognitive pharmacotherapy skills. 
 
Based on the results of the above study, one might assume that the level of 
pharmacotherapy skills could increase considerably by implementing a 
pharmacotherapy teaching programme in the pre-clinical phase of the medical 
education. In Chapter 5: Context-learning, a context-learning programme is 
described and the results of the evaluation are presented. Context-learning 
means learning in the setting of the (future) profession, allowing the student to 
sink in the learned issues by repetitions and giving the students feedback on their 
performances. The students themselves are responsible for ‘repairing’ any lack of 
knowledge. 
The aim of the study was to evaluate a pharmacotherapy context-learning 
programme for 2nd–4th year pre-clinical students with regard to their mastery of 
cognitive pharmacotherapy skills, ready-knowledge of pharmacotherapy and 
study-load, and the appreciation of the programme by the students and the 
examiners. The skills were (1) choosing the (drug) treatment and (2) determining 
the patient information. 
An obligatory context-learning programme for pharmacotherapy skills was 
developed and gradually implemented in the 2nd-4th year training for a total of 
750 students. A weekly session was organised for 108 2nd–4th year students. Each 
session consisted of a recapitulation lecture, a ready-knowledge test (correct 
answers: +1; wrong answers: -1; don’t know: 0) and a role-play session in the form 
of consultations with three ‘patients’. In the role-play session the students played 
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the role of ‘doctor’, ‘patient’ and ‘peer-assessor’. After having attended 15 
sessions, the 4th year students took the Objective Structured Clinical Examination 
(OSCE) in a setting similar to that of the role-play sessions, but more realistic. 
Each student treated three standardised patients in the outpatient clinic during a 
period of 45 minutes, being assessed on a 4-point scale by clinical examiners. 
One year after the full implementation of the programme, in 2002 a random 
selection was made of 192 2nd–4th year students who had played the role of doctor 
in the role-play sessions and 49 4th year students who had taken the OSCE. The 
treatment and the patient information chosen by these students was collected, 
summarised on scoring sheets and assessed again by clinical experts. The scores 
for the ready-knowledge tests and the questionnaires were also collected. 
During the role-play sessions the 2nd, 3rd and 4th year students mastered the 
cognitive skill ‘choosing the (drug) treatment’ at 43.3%, 45.0% and 51.0% of the 
required level for graduation, respectively. The OSCE level was 63.9%. This level 
was significantly lower than that of the group of 6th year students (72.6%: see 
Chapter 3) who had not participated in the context-learning programme. 
During the role-play sessions the 2nd, 3rd and 4th year students mastered the 
cognitive skill ‘determining the patient information’ at 47.3%, 47.2% and 45.3% of 
the required level at graduation respectively. At the OSCE the level was 69.0%, 
which is significantly higher than that of the 6th year students (43.6%: see Chapter 
3). With regard to the ready-knowledge test, the true-minus-false score of the 
2nd, 3rd and 4th year students was 30.1%, 41.8% and 44.8% of the maximum score, 
respectively. The 3rd year students scored significantly higher than the 2nd year 
students. The students had spent approximately 1% of the total study time on the 
pharmacotherapy programme. They appreciated the role-play sessions at 78% – 
82% of the maximum, and the OSCE as much as valued 99% of the maximum. 
It can be concluded that the level of mastering cognitive skills increased in 2nd-4th 
year students because they had participated in the pharmacotherapy context-
learning programme. The level of 4th year students in the OSCE is comparable with 
that of earlier tested 6th year students who had not participated in the context-
learning programme, but who had almost finished their clerkships. This result was 
achieved with a minimum of study-load and a maximum of appreciation by the 
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students for the context-learning methodology, in which the setting resembled 
actual practice. 
 
In the last chapter: the General discussion, the findings of the studies are 
discussed more generally. On the basis of a frequently quoted framework for 
discussing the assessment of clinical skills, competence and performance, with 
the consecutive layers ‘Knowledge’, ‘Competence’, ‘Performance’ and ‘Action’ it 
is explained that the layer ‘Action’ or ‘Performance’ implies the achievement of 
knowledge, as reflected in the more basic layers. On the other hand, assessment 
of the requirements as described in the lower layers does not fully predict the 
achievement in the higher layers. The short training programme described in 
Chapter 4, the context-learning programme presented in Chapter 5, and the 
assessments are discussed within this framework. The consequences for 
educational programmes and assessments are discussed in the light of the findings 
presented in Chapters 4 and 5.  
Suggestions are made for changes in the (medical) education, to include more 
learning by participating in actual practice (‘learning by doing’). Finally, 
recommendations are made for future training programmes and the assessment of 
competence in pharmacotherapy, as well as for future research in this field. 
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Het thema van dit proefschrift is analyse en verbetering van het farmacotherapie-
onderwijs voor studenten geneeskunde. Het algemene doel was het niveau van de 
farmacotherapeutische competentie van bijna afgestudeerde studenten 
geneeskunde te evalueren en, indien noodzakelijk, een onderwijsprogramma te 
ontwikkelen en te evalueren om het niveau van deze competentie te verbeteren. 
Onder farmacotherapeutische competentie wordt verstaan het beschikken over 
toepasbare farmacologische en farmacotherapeutische kennis en vaardigheden in 
therapeutische patiëntproblemen in combinatie met bekwaamheid in het 
(medicamenteus) behandelen van patiënten. Hiertoe zijn vier onderzoeken 
opgezet en uitgevoerd, waarvan de bevindingen hieronder worden samengevat. 
 
In de Introductie wordt beschreven dat er vermijdbare fouten gemaakt worden in 
het voorschrijven van geneesmiddelen en dat er nog steeds irrationeel wordt 
voorgeschreven. Verbetering van het voorschrijfgedrag van praktiserende artsen is 
niet gemakkelijk omdat veel factoren invloed uitoefenen op dit gedrag. Het is 
mogelijk dat basisartsen niet voldoende getraind zijn in het rationeel 
voorschrijven van geneesmiddelen en (daardoor) onvoldoende in staat zijn 
weerstand te bieden aan de factoren die irrationeel voorschrijven tot gevolg 
hebben. 
 
Voordat het niveau van farmacotherapeutische competentie van basisartsen kon 
worden vastgesteld, moesten eerst de eindtermen voor farmacotherapie (eisen 
waaraan de student moet voldoen) worden bepaald. Dit was het doel van het 
eerste onderzoek dat beschreven is in hoofdstuk 2: Eindtermen. Hiertoe werd in 
1995 een gestructureerde enquête gehouden onder de verantwoordelijke 
hoogleraren van relevante klinische afdelingen van alle acht medische faculteiten 
in Nederland. Eerst werden uit de literatuur alle specifieke en algemene 
eindtermen verzameld. Specifieke eindtermen beschrijven de ziektes en 
symptomen, waarvan de basisarts de (medicamenteuze) behandeling dient te 
beheersen. Algemene eindtermen beschrijven de algemene kennis, vaardigheden 
en attitudes waarover de basisarts moet beschikken om deze ziektes en 
symptomen te kunnen behandelen. Per ziektebeeld bepaalden deze hoogleraren 
individueel het gewenste niveau waarover de basisarts moet beschikken, alsmede 
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de mate waarin kennis, vaardigheden en attitudes hiervoor relevant zijn. Om 
zoveel mogelijk overeenstemming over het gewenste niveau te krijgen tussen de 
hoogleraren, is een zogenaamde Delphi procedure gebruikt. Tijdens deze 
procedure worden de deelnemers bij herhaling geconfronteerd met elkaars 
mening via een gestructureerde enquête. In het medisch onderwijs en in de 
klinische praktijk is de Delphi procedure een beproefde methode om de mate van 
overeenstemming vast te stellen over een onderwerp. 
Uit het onderzoek blijkt dat de basisarts de behandeling van 68 (van de 135) 
ziektebeelden en symptomen op het hoogste niveau dient te beheersen 
(professioneel niveau): het zelfstandig kiezen van de (medicamenteuze) 
behandeling en het voorschrijven van geneesmiddelen voor iedere patiënt. Bij 37 
ziektebeelden is het vereiste niveau: het kiezen van de (medicamenteuze) 
behandeling, en bij 9 ziektebeelden: kennis hebben van de geneesmiddelen die 
relevant zijn bij de behandeling. Bij de overige 21 ziektebeelden werd geen 
overeenstemming bereikt over het te beheersen niveau. 
Voor de behandeling van deze 68 ziektebeelden moeten basisartsen beschikken 
over voldoende kennis aangaande basisprincipes van farmacologie en klinische 
farmacologie; alle relevante cognitieve, communicatieve en motorische 
vaardigheden beheersen, en een kritische houding hebben ten aanzien van 
factoren die irrationeel voorschrijven in de hand kunnen werken.  
 
Nadat de eindtermen voor farmacotherapie bepaald waren, werd in het volgende 
onderzoek nagegaan of studenten geneeskunde in Nederland voldoen aan de 
vastgestelde farmacotherapie eindtermen aangaande cognitieve, communicatieve 
en motorische vaardigheden. Dit onderzoek is beschreven in hoofdstuk 3: 
Farmacotherapie competentie. Hiertoe legden 80 6e jaars studenten, afkomstig 
van alle Nederlandse medische faculteiten, twee testen af: een schriftelijke test 
met korte antwoorden (SE) en een stationsexamen (OSCE) in een nagebootste 
praktijksetting met simulatiepatiënten. Tijdens de SE, waarin 27 
patiëntproblemen aan bod kwamen, werden drie cognitieve vaardigheden op het 
gebied van farmacotherapie getoetst: (1) het kiezen van de (medicamenteuze) 
behandeling; (2) het bepalen van de informatie voor de patiënt; (3) het 
vaststellen van het vervolgbeleid. Tijdens de OSCE, bestaande uit 8 consulten met 
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8 patiënten, werden naast deze drie cognitieve vaardigheden ook communicatieve 
en motorische vaardigheden getoetst. De studenten werden tijdens de uitvoering 
van de opdrachten geobserveerd, waarbij de communicatieve en motorische 
vaardigheden direct werden gescoord. De cognitieve vaardigheden van beide 
testen werden later door onafhankelijke beoordelaars gescoord op een 4-
puntsschaal. Deze beoordelaars behoorden tot drie klinische disciplines: 
inwendige geneeskunde, huisartsgeneeskunde en klinische farmacologie, en waren 
afkomstig van drie medische faculteiten. 
Op de SE was de gemiddelde score voor het beheersen van de cognitieve 
vaardigheden in farmacotherapie 55.8% van de vereiste score voor basisartsen en 
op de OSCE 60.7%. De score voor de communicatieve en motorische vaardigheden 
op de OSCE was respectievelijk 73.0% en 53.6%. Therapeutische missers, dat wil 
zeggen een score van 0 of 1 op de 4-puntsschaal, varieerden van 18.6 – 84.1% voor 
alle cognitieve, communicatieve en motorische vaardigheden die tijdens de SE en 
de OSCE werden uitgevoerd. 
De resultaten van het onderzoek bevestigden de mening dat in 1996 in Nederland 
het niveau van de basisartsen niet voldeed aan de eisen volgens de vastgestelde 
eindtermen farmacotherapie aangaande de farmacotherapeutische vaardigheden.  
 
In het huidige onderwijs leren studenten meestal eerst kennis en daarna het 
toepassen van deze kennis in patiëntproblemen. In het volgende onderzoek, dat is 
beschreven in hoofdstuk 4: Vermogen om farmacotherapie te leren gelijktijdig 
met het verwerven van kennis, was het doel om te bepalen of 3e jaars studenten 
geneeskunde cognitieve vaardigheden op het gebied van de farmacotherapie 
kunnen aanleren, dat wil zeggen: (1) de (medicamenteuze) behandeling kiezen; 
(2) de informatie voor de patiënt bepalen, en (3) het vervolgbeleid vaststellen, 
tegelijkertijd met het verkrijgen van de benodigde farmacologische kennis. 
Hiertoe is in 1997 een onderzoek opgezet met een follow-up van 9 maanden 
waarin een controlegroep (42 studenten) het normale onderwijsprogramma 
volgde, en een interventiegroep (43 studenten) een experimenteel programma 
kreeg naast het normale onderwijsprogramma. De 85 deelnemende studenten 
deden vrijwillig mee aan het onderzoek en werden gerandomiseerd toegewezen 
aan een van beide groepen. Dit programma bestond uit een training in 
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farmacotherapeutische vaardigheden gedurende 4 wekelijkse 
groepsbijeenkomsten en zelfstudie. Het programma was identiek aan het 
verplichte programma in farmacotherapeutische vaardigheden voor 5e jaars 
studenten aan het begin van de co-assistentschappen. De 3e jaars studenten 
legden drie testen af, voorafgaand aan en direct na de interventie en na 9 
maanden. De testen bestonden uit een kennistest en een cognitieve 
vaardigheden-test: (1) het kiezen van de (medicamenteuze) behandeling; (2) het 
bepalen van de informatie voor de patiënt; (3) het vaststellen van het 
vervolgbeleid. Als referentie legden 38 5e jaars studenten dezelfde testen af.  
Uit het onderzoek bleek dat bij de test voorafgaand aan het experimentele 
onderwijsprogramma het niveau van de cognitieve vaardigheden van beide 3e 
jaars groepen niet verschillend van elkaar waren (respectievelijk 26.7 en 27.4% 
van het vereiste basisartsniveau). Onmiddellijk na de training was het niveau van 
de interventiegroep gestegen (46.0%) en was 9 maanden na de training niet 
significant gedaald (41.3%). De controlegroep scoorde bij beide testen significant 
lager dan de interventiegroep (36.7 en 36.3%). Het kennisniveau aangaande 
farmacologie en farmacotherapie was niet verschillend tussen de interventie- en 
de controlegroep voorafgaand aan (52.8/53.3% van het maximum), direct na de 
interventie (69.1/66.4%) en na 9 maanden (55.0/55.7%). 
Het niveau van de cognitieve vaardigheden van de referentiegroep van 5e jaars 
studenten voorafgaand aan en direct na hun verplichte training verschilde niet 
veel: 40.3 en 44.5% van het maximum. Het niveau van kennis steeg significant van 
48.8 tot 68.0% van het maximum. 
De conclusie van het onderzoek was dat 3e jaars studenten geneeskunde in staat 
zijn om farmacotherapeutische cognitieve vaardigheden aan te leren tegelijk met 
het verkrijgen van farmacologische en farmacotherapeutische kennis. Het niveau 
van kennis en vaardigheden van de 3e jaars studenten na de interventie gelijk is 
aan dat van de 5e jaars. 5e jaars studenten spijkeren hoofdzakelijk hun 
weggezakte kennis bij en komen nauwelijks toe aan het leren van 
farmacotherapeutische cognitieve vaardigheden. 
 
Op grond van de resultaten van het bovenstaande onderzoek, was het te 
verwachten dat het niveau van farmacotherapeutische vaardigheden aanzienlijk 
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zou kunnen stijgen door het invoeren van een onderwijsprogramma 
farmacotherapie in de pre-klinische fase van de artsopleiding. In hoofdstuk 5: 
Context-gebonden leren, wordt een context-gebonden onderwijsprogramma in 
de farmacotherapie beschreven en de resultaten van een evaluatief onderzoek 
gepresenteerd.  
Context-gebonden leren is leren in de setting van de (toekomstige) 
beroepsuitoefening waarbij de student feedback krijgt op de uitvoering van de 
opdrachten en het geleerde kan beklijven door herhaling. De student is zelf 
verantwoordelijk voor het bijspijkeren van ontbrekende kennis.  
Doel van het onderzoek was de evaluatie van een context-gebonden 
farmacotherapie programma voor 2e–4e jaars studenten aangaande het beheersen 
van farmacotherapeutische vaardigheden, parate kennis over farmacotherapie, 
studielast en waardering van de studenten en docenten. De vaardigheden 
bestonden uit (1) Het kiezen van de (medicamenteuze) behandeling en (2) Het 
bepalen van de informatie voor de patiënt. 
Een verplicht context-gebonden programma voor farmacotherapeutische 
vaardigheden werd ontwikkeld en geleidelijk ingevoerd in het 2e- 4e studiejaar 
voor alle 750 studenten. Hiertoe werd wekelijks een bijeenkomst georganiseerd 
voor 108 2e – 4e jaars studenten. Iedere bijeenkomst bestond uit een 
recapitulatiecollege, een parate kennis toets (goede antwoorden: +1 punt; foute 
antwoorden: – 1 punt; weet het niet: 0 punten) en een Praktijkoefening 
(rollenspel) in de vorm van een spreekuur met drie ‘patiënten’. Tijdens de 
Praktijkoefening hadden studenten de rol van ‘dokter’, ‘patiënt’ en 
‘beoordelaar’. Nadat de studenten 15 bijeenkomsten bijgewoond hadden, legden 
de 4e jaars studenten de Praktijktoets af op soortgelijke wijze als tijdens de 
Praktijkoefening, maar in een realistische setting. Deze studenten behandelden 3 
simulatiepatiënten in de polikliniek binnen 45 minuten, waarbij zij op een 4-
puntsschaal beoordeeld werden door klinische examinatoren.  
Een jaar na volledige invoering van het programma werden in 2002 tijdens de 
Praktijkoefening 192 studenten willekeurig geselecteerd en tijdens de 
Praktijktoets 49 4e jaars studenten. Alle studenten hadden de rol van ‘dokter’. De 
door deze studenten gekozen behandelingen en de verstrekte informatie voor de 
patiënten werden verzameld, overgenomen op overzichten en vervolgens opnieuw 
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beoordeeld door klinische experts. Eveneens werden de scores van de parate 
kennis toets en ingevulde vragenlijsten verzameld. 
Tijdens de Praktijkoefening beheersten de 2e, 3e en 4e jaars studenten de 
vaardigheid ‘Het kiezen van de (medicamenteuze) behandeling’ op respectievelijk 
43.3, 45.0 en 51.0% van het vereiste basisartsniveau. Op de Praktijktoets was het 
beheersingsniveau 63.9%. Dit niveau was significant lager dan dat van de groep 6e 
jaars studenten (72.6%: zie hoofdstuk 3) die het context-gebonden programma 
niet hadden gevolgd.  
Tijdens de Praktijkoefening beheersten de 2e, 3e en 4e jaars studenten de 
cognitieve vaardigheid ‘Het bepalen van de informatie voor de patiënt’ op 
respectievelijk 47.3, 47.2 en 45.3% van het vereiste basisartsniveau. Op de 
Praktijktoets was het niveau 69.0% en dit niveau was significant hoger dan het 
niveau van de groep 6e jaars studenten (43.6%, zie hoofdstuk 3). 
Aangaande de parate kennis toets was de goed-min-fout score van de 2e, 3e en 4e 
jaars studenten respectievelijk 30.1, 41.8 en 44.8% van de maximale score. De 
score van de 3e jaars studenten was aanzienlijk hoger dan die van de 2e jaars.  
De studenten besteedden gemiddeld 1% van de totale studietijd aan het 
farmacotherapie programma. De waardering voor de Praktijkoefening door de 
studenten was van 78 – 82% van de maximaal haalbare waardering en voor de 
Praktijktoets 99%. 
De conclusie van het onderzoek is dat het beheersingsniveau van de cognitieve 
vaardigheden steeg bij 2e-4e jaars studenten omdat zij het context-gebonden 
farmacotherapie programma hadden gevolgd. Het niveau van de 4e jaars 
studenten tijdens de Praktijktoets is vergelijkbaar met dat van eerder geteste 6e 
jaars studenten, die het context-gebonden onderwijs niet hadden gevolgd maar 
wel de co-assistentschappen. Dit resultaat werd bereikt met een minimum aan 
studiebelasting en een maximum aan waardering door de studenten voor de 
context-gebonden onderwijsmethode, waarbij de setting zo veel mogelijk leek op 
de echte praktijk. 
 
In het laatste hoofdstuk, Algemene Beschouwing, worden de resultaten van de 
vier onderzoeken besproken aan de hand van een toetsingsmodel. In dit model 
worden vier lagen onderscheiden: feitenkennis; toepassen van deze kennis in 
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problemen; kennis en vaardigheden laten zien tijdens een toets; kennis en 
vaardigheden uitvoeren in de dagelijkse praktijk. Bij toetsing van activiteiten op 
het niveau van een hogere laag, wordt verondersteld dat de kennis en eventueel 
vaardigheden van een lagere laag beheerst worden. Toetsing van kennis en 
vaardigheden op een lager niveau heeft geen voorspellende waarde voor het 
presteren op een hoger niveau. 
Aan de hand van het model worden het experimentele interventieprogramma uit 
hoofdstuk 4 en het context-gebonden onderwijsprogramma uit hoofdstuk 5 
besproken. Daarna worden de gevolgen beschreven voor het opzetten van 
onderwijsprogramma’s en de toetsing ervan, die voortvloeien uit de bevindingen 
van hoofdstuk 4 en 5. Vervolgens worden veranderingen in het (medisch) 
onderwijs voorgesteld, die vooral gericht zijn op meer leren en ervaring opdoen in 
de dagelijkse (klinische) praktijk. Tot slot worden aanbevelingen geformuleerd 
voor toekomstige onderwijsprogramma’s farmacotherapie en voor toekomstig 
onderzoek hiernaar.  
 
  
 
 
 
 
Appendix 
 116 
Appendix 1  
 
Case number: T90A56 Disease: Diabetes Mellitus 2  
 
Situation: GP practice  Position: doctor-assistant general medicine 
 
General patient information 
name: Mrs J Wesseling * profession: teacher * 
age (date of birth): 63 (12-9-40)   intoxications: -   
sex: female  allergy: -  
civil status: married  pregnancy/lactation:   
children (age): 3 (31; 29; 25)   other: -  
Summary medical history and present health status 
’98: Came to surgery. History: 
 ’88: HNP left L5-S1, treated conservatively.  
 ’96: femur-fracture left after a fall from a step-ladder at work. Post-operative 
physiotherapy; total recovery. 
*
  
’00: sleeping problems due to imminent dismissal: temazepam 14 days (monitoring!)  
* tick off (v) essential pat. data! 
 
 
Essence present findings *) 
 
Mrs Wesseling came to your surgery, because last month she became increasingly thirsty 
and had to go to the toilet 2 – 3 times at night. Moreover, lately she often feels very tired.  
 
After focussed history-taking, diabetes mellitus type 2 seemed to be the most likely cause of 
her complaints. 
 
You have just performed a physical/additional examination: 
- the blood glucose is 12.6 mmol/l (non-fasting) (reference value fasting: 5.6 mmol/l ); 
- the weight is 76 kg at a height of 1.60 m (QI: 30); 
- the blood pressure is 150/85 mm Hg.  
 
You make the working diagnosis diabetes mellitus type 2. 
 
 
 
Assignment: 
Before the consultation (5 minutes):  
 1. Draw up your management/treatment plan. 
 
During the consultation (10 minutes): 
 2a. Inform the patient about your findings of history and examination;  
 2b. Discuss your management/treatment plan with the patient; 
 2c. Execute the management/treatment on the patient. 
*) Only deviating findings are mentioned; other (non-mentioned) data are normal. 
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Case number: T90B65 Disease: Diabetes Mellitus 2  
 
Situation: GP practice  Position: doctor-assistant general medicine 
 
General patient information 
name: Mr JH Geluk * profession: retired porter * 
age (date of birth): 67 ( 12-8-36)  intoxications: -  
sex: male  allergy: -  
civil status: married  pregnancy/lactation: -  
children (age): 3 (38; 35; 30)  other: -  
Summary medical history and present health status 
’96: Came to surgery. History:  
 ‘89: sleeping problems (advice, temazepam 10 days, monitoring!) 
 ’95: diverticulose sigmoid: lactulose syrup 0,5g/g during 4 weeks, motor advice 
* 
’98: light distorsion left knee after fall with bicycle: prescribed rest, if necessary ibuprofen 
for 10 days 
 
’00: spastic colon: mebeverine suspension during 14 days; motor advice.  
’03 dec.: Diab.mellitus 2; bl.gluc. non-fasting: 13 mmol/l; fasting: 9 mmol/l (normal value 
fasting: 5.6 mmol/l ); weight 86kg, height 1.76m (QI:28), RR: 150/90 mm Hg; 
ther.: dietician advice 
 
* tick off (v) essential pat. data! 
 
Essence present findings *) 
 
Mr Geluk came to your surgery. Four weeks ago you diagnosed diabetes mellitus and 
referred him to a dietician for advice about his life-style and nutrition (see summary above). 
He is now visiting you for a check-up of his blood glucose.  
The patient says he sticks to the diet. The complaints, however, remain more or less the 
same (increasingly thirsty, having to go to the toilet 2 – 3 times at night, getting tired more 
often).  
 
After focussed history-taking, the blood glucose appeared to not have declined sufficiently. 
 
You have just performed a physical/additional examination: 
- the blood glucose is 9 mmol/l (fasting; normal value fasting: 5.6 mmol/l ); 
- the weight is 93 kg at a height of 1.76m (QI: 30); 
- the blood pressure is 160/90 mm Hg.  
 
You make the working diagnosis diabetes mellitus type 2, not sufficiently reacting to 4 
weeks of diet. 
 
 
 
Assignment: 
Before the consultation (5 minutes):  
 1. Draw up your management/treatment plan. 
 
During the consultation (10 minutes): 
 2a. Inform the patient about your findings of the history and examination;  
 2b. Discuss your management/treatment plan with the patient; 
 2c. Execute the management/treatment on the patient. 
*) Only deviating findings are mentioned; other (non-mentioned) data are normal. 
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Case number: T90C65 Disease: Diabetes Mellitus 2  
 
Situation: GP practice  Position: doctor-assistant general medicine 
 
General patient information 
name: Mr HB Postma * profession: warden nursing home  * 
age (date of birth): 55 (12-9-48)  intoxications: -  
sex: male  allergy: -  
civil status: married  pregnancy/lactation:  
children (age): 3 (28; 25; 20)  other: -  
Summary medical history and present health status 
’98: History: 
 ‘89: sleeping problems (advice, temazepam 10 days, monitoring!)  
 ’95: diverticulose sigmoid: lactulose syrup 0,5g/g for 4 weeks, motor advice 
* 
’99: Essential hypertension (repeated RR: 200/105 mm Hg); 4 weeks diet no effect; 
started with hydrochloorthiazide; weight: 88 kg, height 1.76 (QI: 28)  
 
’00: Spastic colon: motor advice; later: mebeverine for 14 days; 
 Monitoring RR: 140/90 mm Hg, continue hydrochloorthiazide; weight 86 kg 
 
’01: Astma bronchiale: salbutamol 100 mcg if necessary 1-2 puffs. 
 Monitoring RR: 140/90 mm Hg, continue hydrochloorthiazide; weight 86 kg 
 Bronchitis viral: conservative treatment, relapsing bronchitis: salbutamol 200 mcg if 
necessary 1-2 puffs + beclomethason 200 mcg 2 dd 1 puff 
 
’02  Monitoring RR: 140/85 mm Hg, blood glucose: 7.5 mmol/l (non-fasting), weight 87 
kg. Continue: HCT 25 mg 1 dd; salbutamol 200 mcg if necessary 1-2 puffs + 
beclomethason 200 mcg 2 dd 1 puff; advice: lose 10 kg.  
 
’03 dec.: Monitoring RR: 150/95 mm Hg, blood glucose 8 mmol/l (non-fasting), weight 87 
kg. Continue: hydrochloorthiazide 25 mg, tab, 1 dd 1; salbutamol 200 mcg + 
beclomethason 200 mcg 2 dd ; diet (dietician).  
 
* tick off essential pat. data! 
Essence present findings *) 
 
Mr Postma came to your surgery for a check-up of his blood pressure, blood glucose and 
weight. Since last month, he doesn’t feel very well. He is very thirsty and has to go the toilet 
2 – 3 times at night. Moreover, lately he often feels tired.  
 
After focussed history-taking, diabetes mellitus type 2 appeared to be the most likely cause 
of his complaints. 
 
You have just performed a physical/additional examination: 
- the blood glucose is 13 mmol/l (non-fasting; normal value fasting: 5.6 mmol/l); 
- the weight is 86 kg at a height of 1.76 m (QI: 28); 
- the blood pressure is 150/90 mm Hg.  
 
You make the working diagnosis diabetes mellitus type 2. 
 
Assignment: 
Before the consultation (5 minutes):  
 1. Draw up your management/treatment plan. 
 
During the consultation (10 minutes): 
 2a. Inform the patient about your findings of the history and examination;  
 2b. Discuss your management/treatment plan with the patient; 
 2c. Execute the management/treatment on the patient. 
 
*) Only deviating findings are mentioned; other (non-mentioned) data are normal. 
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Appendix 2 
Extended prescription paper 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Case  Student  
Starting points and management choices 
 
Essential patient information: 
- 
- 
- 
- 
- 
 
Actual patient problem /diagnosis: 
- 
- 
- 
- 
- 
- 
 
Therapeutic goal: 
- 
- 
- 
- 
 
Management/ therapeutic choice: 
- 
- 
- 
- 
-
Name: 
Address:  
Phone 
 
  
 R/ Date: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name patient:  Date of birth: 
Address: 
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Evaluation Competence Pharmacotherapy Test number:        
Date: Case number:        
Name doctor: Student number:        
Name assessor: Student number:        
       Name patient:   
 
Student number: 
 
 
1. Essential patient information, written on the extended prescription paper: i m s e (01) 
Gender; age; (no)co-morbidity; (no)co-medication; 
(no)pregnancy / lactation; (no)allergy; (no)intoxications: 
 
2. Present patient problem, written on the extended prescription paper: i m s e (02) 
Ask for help / complaint; course since start complaint(s); actual seriousness; (diff.)diagnosis:  
 
 
1. The student order additional diagnostics (for / by physician himself): n   i m s e (03) 
To which aim; which diagnostics; to which authority; within what time: 
 
2. The student refer the patient: n   i m s e (04) 
To which (para) medical specialist;  
To which aim (diagnosis / therapy);  
Within what time: 
 
3. The student choose the therapy:  
 a. Therapeutic goal:  n   i m s e (05) 
which aim; when to achieve; to what extent aim has to be reached: 
 b. Non-medicinal therapy / alteration: n   i m s e (06) 
which therapy; how executed; when to start; length of therapy: 
 c. Medicinal therapy / alteration: n   i m s e (07) 
medicine 1: strength; administering form; dosage; tot. quantity 
medicine 2: strength; administering form; dosage; tot. quantity 
medicine 3: strength; administering form; dosage; tot. quantity 
 
4. The prescription of the student is complete and readable: n   i m s e (08) 
Info doctor;medicine;strength;adm.form;dosage;quantity;signature;info patient: 
 
 
1. Patient communication (content) of the student: i m s e (09) 
2. Patient communication (form) of the student:   i m s e  (10) 
3. Attitude of the student:  i m s e  (11) 
4. Patient experience during consultation:    i m s e  (12) 
 
 
1. The student shows knowledge and understanding about the disease of patient: i m s e (13) 
2. The student shows knowledge and understanding of relevant therapy / medicines: i m s e (14) 
3. The student is able to reason with respect to choice(s) monitoring / therapy: i m s e (15)  
 systematic considerations based on: 
 efficiency, safety, suitability, costs 
 
 
B. MANAGEMENT / THERAPY CHOICE AND PRESCRIPTION I M S E 
D. KNOWLEDGE AND ARGUMENTATION I M S E 
C. CONSULTATION (p.t.o. for specific evaluation) I M S E 
E. TOTAL SCORE I M S E 
 n: not relevant; i: insufficient; m: moderate; s: sufficient; e: excellent 
signature doctor: signature assessor: signature patient: 
A. STARTING POINTS I M S E 
Appendix 3  Evaluation form PO and PT 
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1. Patient communication (content) of the student: I M S E (09) 
 
a. Explanation diagnosis / therapy to the patient:   
 Diagnostic findings; diagnosis:  …………………………………………………..………….  i m s e 
 Additional diagostics.; refer: …………………………………………………..…………. n   i m s e 
 Proposal/consultation (no) therapy; prognosis: ..………………………………………….. ………  i m s e 
 
 
b. Explanation effects of therapy to the patient:   
 Which symptoms (do not) disappear:  .………………………………………………..……………. n   i m s e 
 When do symptoms disappear: …………………………………………………..…………..  n   i m s e 
 
 
c. Explanation side-effects of therapy to the patient:   
 Which side-effects can occur:  ……………………………………………………………… n   i m s e 
 What to do if they occur: …………………………………………………..………….. n   i m s e 
 
 
d. Give instructions to the patient:   
 How to take/use the medicine: ……. ………………………………………….……………. n   i m s e 
 How often, how much and how long (cure):………………………………………….. …………….   n   i m s e 
 What to avoid during med. use: ………………………………………………….. …………… n   i m s e 
 
 
e. Make appointments with the patient:   
 Yes / no come back, when: …………………………………………………..…………..   i m s e 
 When come back earlier: …………………………………………………..…………..   i m s e  
 
 
2. Patient communication (form) of the student during consultation:  I M S E (10) 
 Explanation in clear language: …………………………………………………..………….. i m s e 
 Use of reference books: …………………………………………………..………….. i m s e 
 Write during surgery: …………………………………………………..………….. i m s e 
 Check if it is understood: …………………………………………………..………….. i m s e 
 Ask for questions: …………………………………………………..………….. i m s e 
 Other:   ………………………………………………………………. n   i m s e 
 
3. Attitude of the student:  I M S E (11) 
 Attention / respect for (reactions) patient:…………………………………………….……………. i m s e 
 Professional attitude: …………………………………………………..………….. i m s e  
 Other:   …………………………………………………..………….. n   i m s e 
 
4. Patient experience during consultation:    I M S E (12) 
 Explanation disorder and therapy: …………………………………………………..………….. i m s e 
 Instruction and appointments: …………………………………………………..………….. i m s e 
 Attitude doctor: ……………………………………………..……………….. i m s e 
 Other:   …………………………………………………..………….. n   i m s e 
 
Additional remarks 
 
 
C. CONSULTATION (specific evaluation during surgery) I M S E 
 n: not relevant; i: insufficient; m: moderate; s: sufficient; e: excellent 
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Mijn proefschrift is klaar! Al weer 11 jaar gelden ontstond het initiatief hiervoor 
en gedurende de afgelopen 10 jaar heb ik onder andere aan de onderzoeken 
gewerkt die hierin beschreven staan. Onderzoek van medisch onderwijs is alleen 
mogelijk dankzij de bijdrage van de vele studenten, docenten en 
simulatiepatiënten. Iedereen wil ik hiervoor bedanken. Hier kan ik mij niet tot 
iedereen persoonlijk richten. Voor een aantal mensen maak ik echter een 
uitzondering. 
 
Tijdens de bijeenkomsten van de Interuniversitaire Werkgroep Farmacotherapie-
onderwijs onder de bezielende leiding van Cees van Winzum, ontstond het idee 
om te onderzoeken hoe het gesteld was met dit onderwijs. In deze werkgroep was 
ik de enige die nog niet gepromoveerd was. Het lag voor de hand dat ik dit idee 
zou uitwerken tot een project dat misschien zou uitmonden in een 
promotieonderzoek. Cees kon niet meer bij de afronding zijn. 
 
Theo, in de beginperiode was je als ‘kersverse doctor’ nog in Groningen en 
daardoor was je meer op de achtergrond aanwezig. Later werd je benoemd tot 
hoogleraar op het VUmc en nam je de dagelijkse begeleiding over. Ik prijs mij 
zeer gelukkig dat je naar Amsterdam gekomen bent. Nieuwe ideeën over 
onderwijs konden we uitwerken in het laatste onderzoek. Deze samenwerking was 
zeer inspirerend en ik kijk er met veel plezier op terug. Jij was de denker die ik 
als doener nodig had! Jouw goede en eerlijke begeleiding in combinatie met 
unieke ‘peptalks’ waren goud waard. Ik heb in deze jaren veel van je geleerd, 
vooral het ontdekken van mijn sterke en zwakke kanten bij het uitvoeren van 
onderzoek en het verwerken ervan tot leesbare artikelen. Wat betreft het werk 
zijn onze wegen uit elkaar gegaan doordat de drang naar patiëntenzorg sterker 
was dan naar onderwijs en wetenschappelijk onderzoek. Ik waardeer de manier 
waarop je hiermee bent omgegaan. Ik ben er trots op dat ik de eerste 
promovenda ben die bij je promoveert. 
 
Jaap, jij hebt mij in de beginfase begeleid, toen ik - niet gehinderd door kennis - 
aan het project begon. Je gaf steeds nauwkeurig commentaar op mijn 
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manuscripten. Je enthousiasme voor het onderzoeksproject is gebleven, ook toen 
de dagelijkse begeleiding was overgenomen.  
 
Marten, in Indonesië heb ik je leren kennen als een nuchtere en pragmatische 
man met een helikopterblik. Je kunt snel een analyse maken van problemen of 
situaties. Hierdoor ben je onmisbaar geweest in de promotiecommissie. Dat was 
ook het geval buiten deze besprekingen om, omdat je deur altijd open stond om 
goede raad te geven. 
 
Jacqueline, je was onmisbare hulp bij de redactie van het proefschrift en 
bewerkstelligde daardoor een versnelling. Het bleek dat wij meer samen deelden 
dan enthousiasme voor het farmacotherapie-onderwijs. Als de natuur ons 
welgezind is, kunnen we ook tijd besteden aan onze andere gemeenschappelijke 
hobby. 
 
De begeleidingscommissie vanuit de subsidiegevers (Begeleidingscommissie 
Innovatie Farmacotherapie Onderwijs, BIFO) dank ik voor hun kritische vragen, 
nuttige adviezen en het vertrouwen dat in mij gesteld werd. 
 
De leden van de promotiecommissie dank ik voor hun aanwezigheid bij de 
promotie ceremonie. De commissie bestaat uit: prof. dr. Th.J. ten Cate, prof.dr. 
S.A. Danner, prof. dr. R.J.B.J. Gemke, dr. H.V. Hogerzeil, Prof. dr. M. Orme and 
prof. dr. W.A.B. Stalman.  
 
Veel huisartsen en specialisten hebben belangeloos meegewerkt als beoordelaar 
om honderden antwoorden van de studenten te scoren. Zonder hun inzet was het 
onmogelijk geweest. Ferry, ik kon er blind op vertrouwen dat je mij altijd van 
dienst wilde zijn, ondanks je eigen promotieonderzoek en je coördinatorschap 
van het Klinisch Lijn Onderwijs. Het is een eer voor mij dat je paranimf wilt zijn 
bij de verdediging.  
 
In mijn nieuwe werkkring op het Jan van Breemen Instituut, is de belangstelling 
en steun onverwacht groot. Ik ervaar dit als kenmerkend voor de sfeer op het 
werk en ga met vertrouwen mijn toekomst hier tegemoet. 
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Mijn lieve vrienden en familie behoren tot de groep ondersteuners die belangrijke 
randvoorwaarden geschapen hebben om het tot een goed einde te brengen. Jullie 
hebben steeds gemeende interesse getoond en veel geduld opgebracht omdat 
‘het boekje’ de afgelopen jaren steeds nog-net-niet af was. 
 
Lieve Ma, uw wens dat een van de kinderen dokter zou worden, is uitgekomen. 
Dankzij het doorzettingsvermogen dat ik van u geleerd heb, heb ik na 
omzwervingen mijn roeping niet ontlopen en promoveer ik zelfs. Gelukkig kunt u 
er bij zijn. Jammer dat Pa er niet meer is: jullie zouden beiden glimmen.  
 
Lieve Ruud, levensmaatje door dik en dun sinds 1977. We begonnen in 1993 
samen enthousiast aan het opknappen van ons droomhuis en aan mijn 
promotieonderzoek. De planning was om beide klussen in ongeveer 5 jaar te 
klaren. In beide gevallen waren het werk en de bijkomende hindernissen niet te 
overzien; het liep ongelofelijk uit. Achteraf gezien is het de moeite zeker waard 
geweest. Nu het allemaal (vrijwel) klaar is kunnen we trots zijn op de 
voorwaarden die we geschapen hebben om te kunnen genieten en een andere 
invulling te geven aan de ‘p’. Ik verheug mij erop om samen met jouw een 
nieuwe levensfase in te stappen en nog heel lang samen op ontdekkingstocht te 
gaan in onszelf en in de wereld. Bedankt voor jouw onvoorwaardelijke liefde, 
steun en vertrouwen.  
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Joke Vollebregt werd op 17 maart 1954 geboren in Wieringerwerf. Na de 
middelbare school ging zij in 1972 lichamelijk opvoeding studeren aan de 
Academie voor Lichamelijke Opvoeding in Amsterdam. Ze volgde de studie 
Geneeskunde aan de Universiteit van Amsterdam en behaalde in 1988 cum laude 
haar artsexamen.  
Tussen 1976 en 1981 werkte zij als lerares lichamelijke opvoeding op scholen 
voor lager en voortgezet onderwijs. Vervolgens heeft zij tot 1990 gewerkt als 
AGNIO Inwendige Geneeskunde in het MCA (Alkmaar) en het AMC (Amsterdam). In 
1990 werd zij docent vaardigheidstraining van het Algemeen Co-Assistentschap 
(ALCO) aan de faculteit geneeskunde van de Vrije Universiteit te Amsterdam en 
van 1991 tot 1994 hoofd. Van 1994 tot 1997 was zij als onderwijscoördinator 
gedetacheerd op het onderzoeksproject ‘Innovatie Farmacotherapie-onderwijs’. 
Van 1997 tot januari 2003 was zij werkzaam als universitair docent op de afdeling 
Medische Farmacologie.  
 
Het wetenschappelijk onderzoek dat resulteerde in dit proefschrift werd tussen 
1994 en 2003 aan de medische faculteit van de VU verricht.  
 
Van 1990 tot 1993 volgde zij de opleiding Manuele Geneeskunde in Eindhoven. 
Vanaf 1993 tot 2002 heeft zij als arts manuele geneeskunde gewerkt in 
Heemstede en Bussum. Vanaf januari 2003 werkt ze in het Jan van Breemen 
Instituut als stafarts revalidatiegeneeskunde en arts manuele geneeskunde. Haar 
aandachtsgebieden zijn chronische pijnsyndromen en artrose. 
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